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The over-expression of several peptides and proteins in the body often leads to 
catastrophic physiological conditions. Ultimately it would be beneficial to be able 
to reduce the circulation of these peptides. To achieve this, we created systems 
that use synthetic biomaterials to mimic natural biological recognition processes.  
These recognitive polymer systems can be fabricated with molecular 
architectures possessing specific chemical moieties that provide a framework for 
selective recognition of a target analyte in aqueous environments. We 
concentrate on a particular peptide, angiotensin II, which would benefit from a 
system such as this. This work reports on a novel recognitive system that 
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recognizes and captures the undesirable analyte. To achieve destruction of the 
over-expressed peptide for further therapeutic effects, we have incorporated 
biodegradable components into the polymer backbone which create an acidic 
microenvironment, capable of destroying the peptide, upon hydrolytic cleavage at 
the ester bond. 
 
 Imprinted polymer networks were prepared by UV-initiated, free radical 
polymerization reactions of acrylamide as the functional monomer, poly(ethylene 
glycol dimethacrylate) as the crosslinking agent, and angiotensin II as the 
template molecule. To analyze the effectiveness of the imprinting process, 
recognitive/binding studies using angiotensin II and its derivative SVA 
angiotensin were conducted by HPLC. In order to optimize the repeated 
recognition (rebinding) of angiotensin II, the molar ratio of template to functional 
monomer was varied from 1:8, 1:16 to 1:32. The cross-linking ratio was also 
varied from 10% to 80%. The angiotensin II was then placed in various acid 
compositions and analyzed by mass spectroscopy in order to determine its 
integrity in the presence of an acidic microenvironment. The recognition studies 
showed that the networks imprinted for angiotensin II were more selective and 
recognized angiotensin II more effectively than the non-imprinted polymers and 
was more selective for angiotensin II than its derivative peptide SVA angiotensin. 
It can also be seen from studies that the peptide angiotensin II can be degraded 
in the presence of glycolic acid. The synergistic effect of the recognition, 
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capturing and destruction of the peptide ultimately offers promise for novel drug 
delivery systems. 
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1 INTRODUCTION 
 
 
In the past few decades there has been a major shift in research to develop drug 
delivery systems (DDS) that are able to respond directly to a person’s individual 
needs as opposed to responding generically to groups of individuals diagnosed 
with a specific medical condition.  Systems of this nature are able to maximize 
the efficacy of therapeutic agents by rapidly detecting disease states and often 
unnoticeable symptoms, thereby improving the treatment of the patient’s medical 
condition as well as quality of life. This new field is known as “intelligent 
therapeutics” and involves responsive devices and drug delivery systems that 
can detect, capture, isolate and treat undesirable biologicals and trigger an action 
that will release drugs, proteins or therapeutic agents. To achieve such goals, 
one needs to be able to interface synthetic and hybrid materials with dynamic 
biological systems. One promising development in this field is the use of 
molecularly imprinted polymers (MIP).  
 
The expanding field of molecular imprinting technology has an enormous 
potential to create intelligent, analyte-sensitive polymers that are capable of 
controlled drug delivery of therapeutic molecules in response to a biological 
event.  MIP systems have received widespread attention as a new class of drug 
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delivery systems, and as diagnostic tools in molecular sensors in the treatment of 
disease.   
 
MIPs have a large potential for use as DDS whether as the rate-limiting 
mechanism in controlled release systems, as the trigger for the release of a 
therapeutic compound in response to external stimuli or even as the sensing 
element to give feedback as part of a biological sensor. Our lab in particular has 
developed a specific molecular imprinting method termed “configurational 
biomimesis” which produces polymeric surfaces or polymeric recognitive 
networks that have three dimensional, stereospecific binding micro- and 
nanocavities based on a given template molecule. The new synthetic recognitive 
biomaterials have been designed to mimic biological recognition, which is 
ultimately an improvement over using expensive and unstable naturally occurring 
biological macromolecules and ligands. 
 
Configurational biomimesis involves placing a template molecule in the presence 
of unreacted monomer and a crosslinker. These components need to be mutually 
soluble in an inert solvent. It is then possible to introduce an initiator which allows 
a free-radical polymerization to take place. This polymerization produces a mesh-
like network which forms hydrogen bonding complexes with the opposing 
functionalities from the functional monomers and the template. The hydrogen 
bonding can then be disrupted and the template can be removed from the 
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network. The polymer is then left with three dimensional cavities containing free 
functionalities. Ultimately these cavities can reform hydrogen bond complexes 
when contact is reinitiated by the template molecule. The use of configurationally 
imprinted biomimetic polymers (CIBPs) as therapeutic agents holds particular 
promise for treating certain medical conditions.  An example of such a condition 
is the overexpression of certain peptides or proteins in humans.  
 
The concentration of peptide hormones and some proteins rhythmically fluctuate 
as a function of time. Most endocrine rhythms exhibit high-amplitude circadian 
(“about 24 hour”) rhythms. These and other circadian rhythms play a role in the 
pathophysiology of many disease states and may affect the therapeutic efficiency 
and the side effect profile of prescribed treatments.  Hypertension is a prime 
example of a medical condition whose severity, in terms of blood pressure level, 
and response to control by medications are impacted by circadian rhythms [1-3]. 
Indeed, a number of common medical conditions exhibit 24-hour patterns in the 
severity of symptoms or the occurrence of life threatening events. In other words, 
a person who already has a high level of a particular peptide or protein may 
experience further aggravation or triggering of an underlying medical condition at 
the biological time of circulation.  Although many medical conditions show 
specific time patterns, the exacerbation of many medical conditions may not be 
predictable in time and may be precipitated suddenly without prior symptoms with 
catastrophic physiological effects. 
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The peptide hormone angiotensin II plays an important role in blood pressure 
regulation, both in normotensive and hypertensive individuals. The blood 
concentration of this peptide fluctuates throughout the day as a circadian rhythm 
in most persons with peak levels occurring around the commencement of the 
activity span. The circadian pattern can be different, or even absent, in patients 
with certain heart diseases such as congestive heart failure. By inducing the 
activity of mitogenic-activated protein kinases (MAPK’s) angiotensin has been 
shown to stimulate fibroblast production in a dose-dependent manner which in 
certain cases can eventually lead to atrial fibrillation. [4]  
 
Ultimately, it would be beneficial to use polymers that are specifically designed to 
detect (sense) and capture biologicals such as angiotensin II to correct its over-
expression and/or peak concentrations due to circadian patterns in synthesis. 
Unlike typical pharmaceuticals that are used to react to abnormal physiological 
conditions or prescribed as sustained-release formulations so as to attain a 
consistent concentration of medications during the 24-hours, the CIBPs are able 
to neutralize the biological and chemical triggers of disease and thereby prevent 
diseases and their symptoms from occurring. For a complete therapeutic effect, 
the CIBPs will then need to render the over-expressed peptide, whether due to 
circadian rhythms or a pathophysiologic condition, inactive, and then be cleared 
from the body.  
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2 BACKGROUND 
 
2.1 Molecular Recognition 
 
Molecular recognition is the specific recognition of, and interaction with, one 
molecule by another [1]. This ability of molecules to specifically target another 
molecule in a consortium of similar molecules is essential to biological and 
chemical processes.  The process typically occurs through non-covalent 
chemical bonds, including hydrogen bonding or hydrophobic or ionic interactions. 
Ultimately the molecules are both chemically and spatially complementary. This 
process can be seen in many living processes, including in the antigen/antibody 
recognition of the immune system, the binding of an enzyme to a substrate and 
the interaction of a drug to a biological target.  Considered to be natures driving 
force in life, many scientists have sought to mimic this natural process. 
 
2.2 Natural Recognition Systems 
 
The idea of achieving very specific binding of a target molecule readily echoes 
many molecular binding events that occur in most biological systems.  For 
example, the evolved immune systems of higher-order organisms exhibit MIP 
recognition in the complex mechanism of antigen-antibody binding.  Antibodies 
are linear strands of amino acids consisting of two identical polypeptide "heavy 
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chains” (55 kDa) and two identical polypeptide "light" chains (25 kDa) that are 
linked by disulfide bridges to form a “Y” structure [2].  At the N-terminus of the 
chains lies the epitope which contain specific chemical functionalities that lead to 
recognition of a particular portion of an antigen.   
 
It is believed that recognition occurs via ionic or hydrogen complexation between 
chemical functionalities of antigens and amino acids of the epitope (Figure 2.1).  
This complexation then triggers the C-terminus of the antibody to bind to 
phagocytotic cells which consequently engulf and destroy the complex. Many 
researchers are now attempting to mimic this epitope binding to create artificial 
antibodies for the treatment of disease [3].   Mosbach and collaborators [4,5] 
have considered using these “artificial antibodies” as screening of libraries for 
potential new drugs, enzyme inhibitors and as targets for protein binding. 
 
In addition to antigen-antibody binding, proteins themselves contain binding 
domains that contain specific recognition elements for other proteins or 
biomolecules.  Proteins themselves are heteropolymers with specific amino acid 
sequences.  The unique residues of these amino acids dictate the final 
conformation of the protein, and it is these amino acids acting in unison that form 
unique binding pockets for biological molecules [6,7]. 
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Other research groups have attempted to make completely natural recognition 
systems by using proteins as the recognition elements.  Slade [8] lyophilized 
bovine serum albumin in the presence p-hydroxybenzoic acid. Using this 
technique, binding activity could be enhanced by a factor of approximately 3 over 
that of the non-imprinted protein.  In another approach, Motherwell et al. [9] 
placed chicken albumin into contact with an enzyme mimic of glutathione.  By 
crosslinking the albumin with glutaraldehyde in the presence of the mimic, the 
researchers were able to memorize the conformational binding of glutathione to 
the protein.   The imprinted protein exhibited an 80-fold increase in enzymatic 
activity when glutathione was present.  The above two protein-imprinting 
methods not only show that creating natural recognition systems is possible, but 
that they have the possibility of mimicking complex protein-molecule binding 
events to create possible artificial enzyme release systems for the treatment of 
disease. 
 
2.3 Molecular Imprinting 
   
As medical research has expanded and greater understandings of the 
mechanisms of biological molecules have been discovered, researchers have 
tried to replicate natural molecular recognition behavior with synthetic molecules 
and processes.  One method to achieve this is by creating synthetic materials 
that are complementary to biological molecules, both in spatial orientation and 
chemical functionalities, through a process termed molecular imprinting. 
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The precise design of macromolecular architecture which is capable of sensing 
specific molecules has been discussed in the literature for several decades. 
However it has only been in the recent years that these imprinted systems have 
emerged in the forefront of biomedical applications. CIBPs have proven their 
potential as synthetic receptors in several applications. These range from use in 
liquid chromatography columns to assays and sensor technologies for the 
detection of small molecules [10, 11]. 
 
MIP and CIBP technologies involve forming a pre-polymerization complex 
between the template molecule and functional monomers with specific chemical 
structures designed to interact with the template, either by covalent chemistry, 
non-covalent chemistry (self-assembly) or both [12-16]. Once the pre-
polymerization complex is formed, the polymerization reaction occurs by free 
radical initiation in the presence of a crosslinking monomer and an appropriate 
solvent.  When the template is removed, the product is a porous matrix with 
specific recognition elements for the template molecule (Figure 2.2). Thus, CIBP 
creates stereo-specific three-dimensional binding cavities based on the template 
molecule of interest [10, 17, 18].  The resulting polymer networks can then 
specifically recognize the template molecule in solution even when in a mixture of 
other similar molecules. 
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Although molecular imprinted technology has been reported on for several 
decades, there are very few systems that describe imprinting with larger 
molecules such as peptides, proteins and cells. This is due in part to the fact that 
these molecules are often fluid at various conditions and contain large quantities 
of functional charge sites. These biological molecules often contain moieties that 
are both hydrophobic and hydrophilic. It is therefore more difficult to achieve the 
high recognition selectivity that was reported for some of the original molecular 
imprinting systems.   
 
2.4  Molecular Recognition Using Biomaterials 
 
For biomedical applications, typically the most successful CIBP systems are 
ones in which the network is a tightly crosslinked polymeric hydrogel containing 
acrylic or methacrylic functional monomers and poly(ethylene glycol) (PEG) 
derivatives. This is due to PEG’s biocompatible characteristics. It is known to be 
able to evade the components of the immune system. By including PEG as a 
backbone in the hydrogel network, the polymer is able to resist protein and cell 
adsorption. When charged functional monomers such as methacrylic acid or 
acrylamide are added into the PEG based system, pockets of recognition can be 
formed throughout the stealth network, giving way to specific recognitive, 
biocompatible systems.  
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Recent studies have shown superior properties of polymer networks that are 
formed with methacrylates and PEG derivatives [19]. Like PEG, methacrylic 
functional monomers are favored in biomimetic applications because they 
contain anionic acid groups that can non-covalently complex with template 
molecules. This allows for binding and unbinding of the template in the polymer 
network, and echoes natural occurring molecular binding events such as 
molecular receptor and antibody-antigen recognition. In antigen-antibody binding, 
it is believed that recognition occurs via ionic or hydrogen complexation between 
chemical functionalities of antigens and amino acids of the epitope. 
 
2.4.1  Degradable Recognition Systems using Poly(α-hydroxy ester)s as 
Degradable Components  
  
In trying to create systems that are biocompatible, researchers have also placed 
a large emphasis on creating degradable systems. This is because the ability to 
form recognitive degradable networks using a controlled degrading structure has 
important applications for the treatment of medical conditions, including the use 
in drug-delivery devices and tissue engineering constructs.  These constructs 
degrade and allow the implant or delivery devices to be easily removed by the 
body’s reticular endothelial system (RES) and avoid the need for extra surgeries 
for removing foreign body devices. Poly(α-hydroxy ester)s such as poly(lactic 
acid) (PLA), poly(glycolic acid) (PGA) or combinations of the two (PLGA) have 
been widely studied and used for such devices. These polymers have ester 
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linkages that can be hydrolytically cleaved, and that they are known to be 
extremely biocompatible [20].  
 
PLA, PGA, and PLGA are also among the few synthetic polymers that have been 
approved by the Food and Drug Administration (FDA) for certain human clinical 
applications. These polymers can be tailored to degrade by designing specific 
combinations of the PLA and PGA. PGA has an extremely hydrophilic nature and 
therefore will degrade at a high rate in physiological conditions. PLA, on the other 
hand, has an extra methyl group which makes it more hydrophobic and causes it 
to degrade more slowly. Although there has been a lot of emphasis on tailoring 
specific degradation rates, these polymers undergo heterogeneous degradation 
as a result of several simultaneous in vitro and in vivo processes.. Some of these 
processes include water uptake, swelling, ester hydrolysis, oligomer diffusion, 
degradation products, and local pH drop [21-23].  
 
Diffusion of degradation products out of the polymer structure and into the 
surrounding medium has been reported to be hindered in larger polymers. This in 
turn leads to an accumulation of acidic degradation products and a subsequent 
pH decrease inside the polymer object. The result of the local pH drop inside the 
polymer leads to autocatalysis and further local degradation. Therefore, although 
these polymers undergo bulk erosion, there is more rapid degradation in the 
center than at the edges. Langer and colleagues have reported that when these 
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polymers are placed in pH 7 phosphate buffered solution (PBS) at 37°C and 
allowed to degrade, the acid buildup in the center of the polymers can lead to a 
local pH drop below pH of 3 [21]. 
 
2.5 Applications of Molecular Recognition Systems 
 
 
The field of molecular imprinting has flourished in the past two decades, and 
several systems have been used successfully in practice. In particular, 
molecularly imprinted polymers show a lot of promise in chromatography and 
separation columns [10]. However, recently the field has expanded to include 
potential drug-delivery and pharmaceutical applications.   
 
Of recent note DDS are the efforts by our group and others to use 
environmentally responsive, MIP hydrogels as carriers for controlled release of 
therapeutic compounds.  Hydrogels have been used as prime carriers for 
pharmaceutical applications, predominantly as carriers for delivery of drugs, 
peptides or proteins. They have been used to regulate drug release in reservoir-
based, controlled-release systems or as carriers in swellable and swelling 
controlled-release devices [24-26].  Hydrogels can be rendered sensitive to 
physiological conditions due to the presence of specific functional groups along 
their backbone polymer chains. The swelling behavior and associated release 
kinetics of these gels may be dependent of pH, temperature, ionic strength, or 
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even drug concentration [25]. The technology has evolved to achieve sustained 
delivery of large molecules, such as high molecular weight peptides for long 
periods of time (e.g., days and months), and certain groups have recently used 
MIP polymers to administer the sustained controlled release of small-molecular 
weight drugs for therapeutic purposes.  For example, PEG hydrogels as contact 
lenses have been composed with imprinted sites for the drug timolol [27].  The 
interaction of the imprinted sites with timolol must be overcome by the uptake of 
water and this slows the release of this drug into the eye.  Thus, MIP contact 
lenses exhibited longer release times than non-imprinted polymers loaded with 
the drug [27-28].  
 
Unfortunately, current DDS are often limited because they cannot respond in a 
real time mode to the biological needs of a patient.  Every person’s physiology 
and pathological conditions vary slightly.  Medical conditions also vary through 
the course of time, and many disease states often possess unpredictable 
episodes or unnoticeable symptoms that may lead to catastrophic physiological 
effects.  Therefore, it would be advantageous of future DDS to function on a real 
time basis so as to be able to accurately sense and determine changes in 
significant biological markers and then actively respond by releasing a 
therapeutic agent or a sensible signal.  Ideally these systems should also be able 
to self regulate and effectively be able to switch on and off depending on the 
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therapeutic need.  Some of the recent developments in actively responding 
systems are described below.  
 
Tanaka and collaborators [28-32] have described one recognition system in 
which polymer gels recognize molecules in a manner very similar to the process 
in which proteins recognize them. In other words, recognition capabilities are 
based on a specific molecular conformation, and these gels are able to change in 
and out of a particular conformation based upon environmental cues, such as 
ionic strength, temperature, or pH.  These gels are able to memorize certain 
configurations based on spatial assemblies of groups of their monomers. 
Essentially, this group creates a thermo-sensitive polymer, and then polymerizes 
previously end-shielded post-crosslinking monomers in the presence of a 
template or target molecules (negatively charged molecules that interact with 
positively charged functional monomers), and the resulting gel is a MIP network 
with thermo-responsive properties. 
 
When Tanaka et al. compared the recognition aspects of the gel, it was shown 
that the presence of the template during the additional post-crosslinking step 
resulted in 3-5 times higher affinity compared to random post-crosslinking. They 
were also able to show that the functional monomers with carboxyl groups 
formed complexes with divalent ions when polymerized, but upon swelling the 
affinity for the divalent ions disappeared. However, when the temperature was 
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increased the gels would shrink, the affinity was recovered, and the original 
relative position of the carboxyl groups were recalled in effect memorizing the 
original polymer formation. Non-imprinted gels had decreased affinity for divalent 
ions and trouble forming pairs due to polymer frustrations. 
 
Although these MIP systems show multiple-point absorption, they have yet to 
recognize molecules other than charged species. However, it is interesting to 
note that the presence of acidic groups is a common feature in drug substances 
including antibiotics, glucocorticoids and cholinergic drugs [33].  Future uses of 
these systems show great promise in the drug-delivery field due to the 
reversibility of drug release and re-uptake as a function of temperature. They 
could be applied to pathological conditions which involve local changes in 
temperature or by triggering the on/off release of drug due to externally applied 
local hyperthermia. 
 
Perhaps a more specific active recognition/release process is one using a 
competitive binding system. This system could respond to the individual patient’s 
therapeutic requirements and deliver a specific amount of drug in response to a 
biological stimulus [34].  An example of this system is a reversible antigen 
responsive hydrogel [35]. This gel uses the reversible binding between an 
antigen and an antibody as the crosslinking mechanism in semi-interpenetrating 
networks (semi-IPNs). Miyata et al. [35] synthesized a semi-IPN which consisted 
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of a polymer containing rabbit antibody (IgG) and goat anti-rabbit as the antigen. 
Upon placing free antigen, rabbit IgG, into a solution with the IPN, the hydrogel 
swelled.  This is due to the competition between free and polymer-immobilized 
antigen. The group was also able to show that the hydrogel swelling was 
reversible by removing the free antigen, and that this relationship was based on 
free antigen concentration.  In order to demonstrate the relevance this system 
has in a DDS, drug was entrapped in the network and shown to release 
proportional to stepwise changes in antigen concentration.  While not an MIP 
system, this network shows once again that hydrogel systems could be tailored 
to release a drug in response to an external stimulus.  
 
The competitive binding method outlined above can be extended to creating 
networks that include non-imprinted drugs that are released when the template 
molecule appears in the surrounding medium.  For this application, the MIP 
network must possess a weak affinity for a therapeutic drug and a strong affinity 
for the template molecule.  When in the presence of the imprint molecule, the 
network binds this molecule, which consequently leads to the release of drug. 
Such an MIP system has been shown to release hydrocortisone upon recognition 
of testosterone [33]. Other MIP competitive binding systems include the use of 
anesthetic drugs, methylzantines and/or other sterols to trigger the responsive 
release of drug [33].  
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There are several physiological and pathological conditions that release 
particular analytes as direct indicators of the progression of the disease state. 
Therefore, a need exists to develop systems that are environmentally responsive 
hydrogels for given analytes. These analyte sensitive systems could be 
molecularly recognitive for biologicals produced at certain intervals and be able 
to release therapeutic agents in response. One such system is a calcium–
responsive bioerodible DDS devised by Goldbart and Kost [36].  This system is a 
starch-cellulose matrix that contains α-amylase, which is a biological protein 
regulated by calcium. As calcium enters the hydrogel system, bound α-amylase 
binds with this ion and is cleaved to become active.  This active calcium can then 
be utilized by the body, and these gels can eventually be used to treat calcium- 
dependent diseases such as osteoporosis. 
 
In future technologies, imprinted gels or chains possessing certain 
macromolecular architecture with binding abilities could be used as the sensing 
elements within analyte-sensitive controlled-release systems. The design and 
implementation of imprinted recognition release systems would be challenging, 
but certainly one can envision imprinted gel films loaded with therapeutics.  It 
could be reasoned that binding of target molecules to active sites or specific 
chemical groups could change the overall ionic character or hydrophilicity or 
hydrophobicity and in turn cause the swelling of a polymer gel for release of a 
drug.  Kataoka and coworkers [37,38] have shown this effect using a hydrogel 
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that contains a borate-glucose complex.  These gels exhibit a sharp transition in 
degree of swelling with respect to glucose concentration. As glucose binds, the 
network becomes more hydrophilic due to the formation of a charged template-
binding group complex. Thus, as the authors speculate, this type of polymer gel 
can be used as a chemical valve to regulate drug release in response to glucose 
concentration, for use as a DDS in the treatment of diabetes.  
 
A particularly promising idea is the use of imprinted systems in medical 
applications that impose the principles of chronobiology. Recently, there has 
been much attention given to chronopharmacological DDS.  These DDS are 
designed to synchronize the delivery of therapeutic agents to biological rhythm 
(24-hour and other periods)-driven requirements.  These systems are very 
important especially in the area of endocrinology and in delivery of vaccines.  For 
example, it has been shown that the treatment of hypopituitary dwarfism by 
administration of human growth hormone releasing hormone (GHRH) is more 
effective when the GHRH is administered in a pulsatile manner [39]. 
 
It is a common practice in clinical pharmacology to assume the pharmacokinetics 
and pharmacodynamics of medications are not influenced by the time of day 
(with reference to circadian rhythms) of their administration. However, there is 
convincing evidence that shows this assumption is not always valid.  It is now 
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well established that nearly all functions of the body, including those influencing 
pharmacokinetic parameters, display significant circadian variation [40,41]. 
 
These new findings have lead to the development of a new research area, that of 
chronopharmacology, which is a study of coordinating biological rhythms 
(chronobiology) with medical treatments.  Chronobiology is the study of the 
body’s biological rhythms and time structure.  All living creatures evolved in a 
setting that is characterized by predictable changes in time, e.g., cyclic 
relationships of the sun, earth and moon.  Early life-forms were strongly helio-
dependent.  Living organisms had to store energy during periods of daylight for 
use during periods of darkness.  Adaptability to the influence of the circadian 
patterns of our planet was a condition of life, and it is apparent that all organisms 
have incorporated and retained vital circadian and other periodicities in their 
genetic code. 
 
Many chronic and acute disorders have a prominent circadian pattern of 
symptom appearance and severity.  For example, (i) allergic rhinitis is an early 
morning disorder, (ii) patients with epilepsy have seizures during the day only, or 
the night only, or some have a more random pattern.  (iii) peptic ulcer disease is 
worse late at night and early morning hours when the acid secretion of the 
stomach is the highest [42], (iv) asthma attacks typically occur during the night 
[43-45], (v) thrombotic and hemorrhagic stroke risk are greatest in the morning 
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while (vi) cholesterol synthesis is greater in the late evening [46].  Several 
cardiovascular diseases show circadian patterns, such as myocardial infarction, 
stroke and angina pectoris [47, 48].   
 
The future applications of molecular imprinting could have major implications for 
chronotherapy. By introducing MIP polymers into the bloodstream, it is possible 
for them to preferentially bind to over-expressed undesirable biologicals when 
they are in their elevated state and ultimately reduce them to safe plasma levels 
before any negative physiological effects occur (Figure 2.3). 
 
2.5.1  Angiotensin II and the Renin-Angiotensin-Aldosterone System 
 
Novel imprinted chronotherapeutic systems would be particularly promising when 
trying to regulate over-expressed peptides or proteins, whether at particular times 
of the day and night and/or throughout the 24-hours. Angiotensin II is an example 
of peptide that is often overexpressed and could benefit from such a therapeutic 
system.  
 
The renin-angiotensin-aldosterone system (RAS) is a well defined complex 
regulatory system with many identifiable actions. However it is best known for 
being a regulatory system for the conservation of salt and blood volume, and the 
preservation of blood pressure. The major end product of the RAS cascade is 
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angiotensin II. Angiotensin II is the active form of angiotensin I. Angiotensin I is 
first cleaved by an angiotensin converting enzyme (ACE) which creates 
angiotensin II. Angiotensin II then acts on either type 1 or type 2 angiotensin 
receptors.  
 
Angiotensin II is an octapeptide with the following structure: asp-arg-val-tyr-ile-
his-pro-phe. It is naturally cleaved by three aminopeptidases in the body which 
are call aminopeptidase A, B, and C. Aminopeptidase C cleaves the angiotensin 
II between the seventh and eighth amino acid to create angiotensin (1-7). It is 
this form of angiotensin that counteracts the effects of the angiotensin II. The 
most common way to treat a patient who displays an over-expression of 
angiotensin II is to administer ACE inhibitors or angiotensin receptor blockers 
(ARBs). However, both these treatments can exert side effects, including birth 
defects, and ACEs, in particular, are known to elevate potassium levels and to 
induce cough and dizziness. Extreme side effects include kidney failure and 
decrease of white blood cells [49]. 
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2.6 Figures 
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Figure 2.1: Antigen/Antibody Molecular Recognition 
Antibodies are “Y” structures that recognize antigens via a very specific 
arrangement of amino acids. [18] 
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Figure 2.2: (1) Template molecules are mixed with free functional monomers 
and crosslinking agent.  (2) Functional monomers bind to reactive sites on the 
surface of the template molecule.  (3) The monomers react with the crosslinker to 
form a crosslinked template through UV photopolymerization.  (4) Molecules are 
washed from the template leaving a recognitive scaffold.  (5,6) New molecules 
occupy spaces formerly held by the template molecules. [18] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
25
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3: Schematic showing that the presence of imprinted microspheres in 
the blood are able to absorb undesired biologicals and reduce their concentration 
in the plasma to safe levels. 
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3 OBJECTIVES 
 
 
The objective of the work here has been derived from the main hypothesis which 
is that tailor-made biodegradable CIBPs can recognize angiotensin II using 
acrylamide and related comonomers. The ensuing materials can act as 
biologically responsive carriers for drug delivery. Thus, a new generation of 
intelligent, responsive drug delivery systems will be created. 
   
The specific aims of this research are as follows: 
 
(1) To fabricate, optimize and characterize nondegradable polymer 
systems prepared from configurationally imprinted biomimetic polymers 
which specifically recognize angiotensin II. 
 
(2) To synthesize and characterize a hydrolytically cleavable poly(α-
hydroxy ester) crosslinking agent (crosslinker). 
 
(3) To fabricate degradable configurationally imprinted biomimetic 
polymers and characterize their physicochemical effects and chemical 
interactions with the template peptide angiotensin II.  
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(4) To conduct an in vitro characterization of the configurationally 
imprinted biomimetic polymers, measuring the biocompatibility of the 
constructs and the cytotoxicity of the degradation products. 
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4 FABRICATION OF NONDEGRADABLE CONFIGURATIONAL 
BIOMIMETIC IMPRINTED POLYMERS SELECTIVE FOR ANGIOTENSIN II 
 
4.1 Introduction 
 
 
By explicitly choosing components and tailoring reaction conditions it is possible 
to effectively design a polymer network that is specifically imprinted for an 
undesirable biological. These polymer networks will then be able to rapidly 
recognize the biological molecules in physiological conditions.  
 
When designing experimental conditions, several factors need to be considered. 
Specifically it is important to examine template interactions with functional 
monomers, percentage of crosslinker, and the solvent conditions in which the 
reaction will be run. Choosing the functional monomers that will be used is based 
on the template’s size and charges.  
 
In configurational biomimetic imprinting, recognition occurs through specifically 
localized hydrogen bond complexes. It is therefore desirable to choose 
monomers that can provide opposite hydrogen bonding functionalities to the 
template molecule. Since these systems will ultimately be placed in physiological 
conditions, it is also important to mimic natural functionalities of amino acids and 
ensure biocompatibility. The next factor that needs to be considered is choosing 
the appropriate amount of crosslinker for the mesh network. The recognition is 
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based upon specifically sized binding cavities. If an insufficient amount of 
crosslinker is used, the binding cavities will swell and distort in solution. However, 
if too much crosslinker is used, the network that will form will be so dense that 
the template would be unable to move into and out of the system. Finally a 
solvent needs to be chosen in which all components will be mutually soluble and 
for which the template will have a similar hydrodynamic radius to what it has in 
physiological binding conditions. 
 
With the above considerations in mind, the components of the system that 
specifically recognizes angiotensin II were chosen to be poly(ethylene glycol) 
monomethacrylate and acrylamide as the functional monomers, poly(ethylene 
glycol) dimethacrylate as the crosslinking agent and dimethyl sulfoxide (DMSO) 
as the solvent (Figure 4.1).  
 
4.2  Materials and Methods 
 
4.2.1 Fabrication of Angiotensin II Imprinted Polymers 
 
Imprinted polymer networks were prepared by fast, UV-initiated, free radical 
polymerization reactions of acrylamide and poly(ethylene glycol) 
monomethacrylate 400 (PEGMA 400)  as the functional monomers, 
poly(ethylene glycol) 1000 dimethacrylate (PEGDMA 1000) as a comonomer and 
the crosslinking agent, and angiotensin II as the template molecule. 
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In a typical synthesis of an imprinted network, 0.095 g of (PEGMA 400) 
(Polysciences Warrington, PA.), and 0.13 g of acrylamide (AAm) (Sigma-Aldrich, 
St. Louis Missouri), were placed in an amber bottle and dissolved in 0.6707 g 
DMSO (Fisher Scientific). The monomers are in a 1:1 molar feed ratio of ethylene 
glycol units:AAm. Then 0.027 g of angiotensin II was added. The solution was 
allowed to sit for 20 minutes in order to form prepolymerization complexes. Then 
0.2255 g of (PEGDMA 1000) crosslinker was added. After the monomer solution 
was mixed and allowed to go into solution, the photoinitiator 1-hydroxyclyclohexyl 
phenyl ketone (Irgacure 184®) (CIBA-GEIGY Hawthorne, NY) was added.  
 
The amber bottle was then covered with parafilm and placed in a nitrogen 
atmosphere. A needle was placed through the parafilm and nitrogen was allowed 
to bubble through the solution for 20 minutes in order to remove the oxygen, a 
free-radical scavenger. The solution was then pipetted between two glass plates 
which were separated by a 700 μm Teflon spacer. The glass plates were then 
exposed to UV light (Dymax 2000_EC Light Curing System, Torrington, CT) for 
20 minutes at an intensity of 16 mW/cm2. The resulting polymer was then 
removed from the glass plates and washed in a 300ml solution of acetonitrile with 
5% acetic acid for 7 days. This was to ensure template extraction and the 
removal of any unreacted monomer.  The polymer was then dried in a vacuum 
oven at 35°C for 2 days. It could then be cut into 12 mm diameter disks or 
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crushed into particles ranging in size from 75-150 μm. Control polymers were 
synthesized in the same manner with the exception that no angiotensin II was 
added. 
  
In order to optimize the recognition of the polymer for angiotensin II the 
previously described synthesis was performed several times, varying first the 
molar ratio of template to functional monomer and then varying the crosslinker 
mole percentages in the formulations. The various ratios of template to functional 
monomer were 1:8, 1:16 and 1:32. After determining the best template to 
monomer ratio, the crosslinker percentages were varied. The various 
formulations that were produced included networks with 10 mole%, 20 mole%, 
40 mole% and 80 mole% PEGDMA 1000. 
 
The polymer formulation with the most specific recognition was then used as a 
template for adding a third functional monomer in order to increase recognition. 
The third monomer that was added was methacrylic acid (MAA). The networks 
were fabricated as previously described with the exception that MAA was added 
in a 1:1:1 molar feed of EGMA:AAm:MAA. 
 
4.2.2 Template Removal Study 
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In order for selective recognition/binding to be successful, it is important to 
remove the original template from the binding cavity. Studies of the wash 
solutions were therefore conducted to determine that the template had been 
removed from the polymer. After each wash, three 200 μl samples of solution 
were placed in a UV/Vis 96-well plate. This plate was then read by a UV/Vis 
microplate reader at a wavelength of 215 nm. The results were then compared to 
a standard curve of angiotensin II concentrations. They were then subtracted 
from the initial amount of angiotensin II added during synthesis.  
 
4.2.3 Swelling Studies 
 
 
The imprinted networks were then evaluated by performing dynamic swelling 
studies. Briefly the swelling studies were performed by placing dry polymer disks 
(12 mm diameter) in a solution of pH 7.4 PBS at 37°C. Ionic strength was 
controlled with sodium chloride. The disks were removed, blotted dry and 
weighed at regular intervals for 20 minutes. The weight swelling ratio, q, was 
calculated as the swollen weight/dry weight of the polymer disk. The time allowed 
for swelling was calculated by using an approximation of in vivo swelling as 
shown below: 
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where t is time, l is the thickness of the of the film, and D is the diffusion 
coefficient of water into the dry film.  
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4.2.4  Specific Recognition Studies 
 
 
To determine if angiotensin II was successfully imprinted into the polymer 
networks, recognition studies were performed. The various polymer formulations 
were placed in the presence of angiotensin II or SVA angiotensin. SVA 
angiotensin is a synthesized derivative of angiotensin II in which three amino acid 
moieties were substituted. Its structure is ser-arg-val-tyr-val-his-pro-ala. It has a 
molecular weight of 958 and a charge at pH 7 of +1. Both of these characteristics 
are similar to angiotensin II. The binding studies were also conducted in both 
DMSO, the solvent used during the synthesis, and phosphate buffered solution 
(PBS) with a pH of 7.4. The latter was used to simulate physiological conditions.  
  
In a typical experiment, dry imprinted polymers were cut into 12 mm diameter 
disks and weighed. A disk was then placed into a 15 ml conical tube which had 
either solutions of 1mg/ml angiotensin II in DMSO, 1 mg/ml angiotensin II in PBS, 
1mg/ml SVA angiotensin in DMSO or 1 mg/ml SVA angiotensin in PBS. Nano 
imprinted control polymers of the same formulation were also cut into 12 mm 
disks, and placed into their own 15 ml conical tubes containing the solutions 
described above. The tubes were then placed on a rotating mixer set at 25 rpm. 
At time points of 0, 1, 2, and 3 hours, three 200 μl samples of supernatant were 
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removed and placed into a UV/Vis 96-well plate. The plates were then read by a 
UV/Vis microplate reader at a wavelength of 215 nm. The results were then 
compared to standard curves of known concentration of both angiotensin II and 
SVA angiotensin. The peptide concentration in the supernatant was determined 
from this. This concentration was then subtracted from the original solution 
concentration. The final result was then divided by the weight of the original dry 
polymer to determine mg bound/mg polymer. All experiments were repeated in 
triplicate for each formulation of the polymer.  
 
The best polymer formulation was then tested for specific recognition against a 
physiologically relevant peptide. The binding studies were performed as 
previously described; however, instead of using SVA angiotensin, another 
synthesized peptide which is present in the blood stream, antidiuretic hormone 
(ADH), was used. ADH is a biologically relevant peptide which is of similar size to 
angiotensin II. It consists of the nine amino acids: cys-tyr-phe-gln-asn-cys-pro-
arg-gly. 
 
4.3  Results and Discussion  
 
4.3.1 Template Removal Studies 
 
For a recognitive system to be successful in recognizing its template molecule, it 
is important to ensure that the template used during the polymerization process 
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is completely removed from the system. This ensures that the binding cavities of 
the imprinted networks are free to interact with the templates placed in the 
binding solutions. The polymer networks were therefore examined in order to 
determine that the original template molecules were completely removed from 
the system.  
 
The results of the template removal study can be seen in Figure 4.2. In all cases 
approximately 87% of the original template was removed. There are several 
possibilities to explain the remaining 13%. One explanation would be that it is 
permanently entrapped in the polymer. It is also possible that due to 
polymer/template thermodynamic interactions, the template was not 100% 
soluble in the prepolymerization solution [1]. If the template was not completely 
dissolved, it is possible that it was not actually incorporated into the network 
during the polymerization process. Finally, it is possible that a small quantity of 
the template is located deep within the polymer network and takes more time to 
diffuse out. If it leaves the polymer in extremely small quantities, it may be 
outside the sensitivity range of the UV/Vis and therefore undetectable.  
4.3.2 Specific Recognition Studies 
 
The goal of the design of the imprinted network was to create a system that was 
sensitive in recognizing its template molecule when compared to the sensitivity of 
the nonimprinted control network, and to create a system that was selective for 
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that template over competitive molecules. To assess the success of such an 
imprinted network, recognition studies were performed. To achieve the most 
recognitive network, molar ratios of the template to functional monomers and the 
molar crosslinking percentages were varied and investigated. The most sensitive 
network was then tested for its selectivity over competitive peptides.  
 
The calculations for recognition were based on the amount of equilibrium peptide 
recognition, Prec (units of mg-peptide/g-polymer), in the polymers. It was 
calculated by a simple mass balance: 
 
p
mequilibriuinitial
rec M
CCV
P
)( −=    (4.2)   
 
where Cinitial is the starting peptide concentration, Cequilibrium the final concentration 
after of peptide in supernatant after loading, V the volume of peptide solution, 
and Mp the mass of polymer disks used.  The percentage of recognition of MIP to 
control was then calculated. In our case the original concentration of peptide in 
solution was kept at 15 mg/ml and the polymer disks weighed approximately 
0.368 g. Therefore the maximum possible amount of mg peptide bound to grams 
of polymer was determined to be 40.76. This was considered to be 100% 
binding. The results are therefore reported as a percentage of this binding.  
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In the first test of recognition, the imprinted networks were investigated for 
sensitivity against their nonimprinted controls by varying their molar template to 
functional monomer ratio. The goal of this experiment was to determine the 
optimal ratio of free monomer functionality to the complimentary template 
functionality.  An excess of free monomer functionality can lead to the polymer 
being charged which can cause nonspecific absorption of molecules. On the 
other hand, if there is not a high enough ratio of monomer functionality to the 
complimentary template functionality, the recognition cavities in the polymer will 
not have enough specific sites to selectively recognize the template.  
 
The recognitive network used in this study was poly(ethylene glycol-g-
acrylamide) with a 20 mol% crosslinking density. The molar ratios of template to 
functional monomer were varied to be 1:8, 1:16 and 1:32. These values were 
chosen based on typical literature values [2]. The results of this recognition study 
can be seen in Figure 4.3.  The 1:8 recognitive network was determined to be 
approximately 22% more sensitive than its nonimprinted control. The 1:16 and 
1:32 were determined to be 20% and 8% more sensitive, respectively. Therefore 
the 1:8 molar ratio was chosen to be the optimal ratio for this network.  
 
Another important aspect in optimizing the recognition of the networks is 
determining the optimal crosslinking percentage. This is due to the fact that the 
recognitive networks are hydrogels and have the propensity to swell. This 
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swelling is partially based upon how loosely crosslinked the systems are. If the 
networks are too loosely crosslinked they will exhibit a large amount of swelling 
and could ultimately affect the stereo-specific three dimensional space of the 
recognitive cavity. Without correctly positioned monomer functionality in the 
recognitive cavity, the imprinted network will loose the ability to be sensitive for 
its template. On the other hand, if the network is too tightly crosslinked, 
molecules, including the template molecule, will experience difficulty moving 
through the network. This will ultimately reduce the time in which the system can 
detect the imprinted molecule and could possibly reduce the total amount of 
template detected. 
 
With the above considerations in mind, the poly(ethylene glycol-g-acrylamide) 
network with a 1:8 template to functional monomer molar ratio was varied to 
contain crosslinking percentages of 10 mol%, 20 mol%, 40 mol% and 80 mol%. 
The results can be seen in Figure 4.4. The recognitive network exhibited 17% 
sensitivity to its nonimprinted control when it contained 10 mol% crosslinker. It 
exhibited a sensitivity of 21% for the 20 mol%, 25% for the 40 mol% and 
approximately 14% for the 80 mol%.  
 
In order to further increase the recognition capabilities of the polymer network, a 
third functional monomer was included. Methacrylic acid was added to the 
network to add potential ionic bonding sites which ultimately provides more 
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complementary function to the template molecule angiotensin II.  Recognition 
studies showed that the addition of the third functional monomer did slightly 
increase the recognition of the network to approximately 28% (Figure 4.5).  This 
could be in part due to the fact that methacrylic acid, the third functional 
monomer, provides ionic bonding sites. Purely covalent bonding, such as 
hydrogen bonding, is not always the most efficient way to recognize, because 
there is often competition between the solvent and the template. Therefore by 
introducing non-covalent bonding sites, it is possible to increase recognition [3]. 
 
Finally, it was the goal of this work to not only create a sensitive recognitive 
system, but also a highly selective one. Therefore, the most recognitive 
formulation of pegylated  poly(acrylamide-co methacrylic acid) with a template to 
functional monomer molar ratio of 1:8 and a crosslinking percentage of 40 mol% 
was tested for its selectivity by performing recognitive studies with competitive 
peptides (Figure 4.6). The polymer was 27% more selective for angiotensin II 
than the synthetic SVA angiotensin. However when the polymer was compared 
to the physiologically available ADH, the selectivity was increased to 32%. 
 
The aforementioned recognition studies were conducted in DMSO, the solvent 
used during the synthesis process. However, with the ultimate goal being to 
develop systems that can be used in physiological environments, the recognitive 
polymers were also tested for their selectivity and sensitivity in a physiologically 
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relevant solvent, PBS (Figure 4.7). Although recognition in PBS is decreased 
compared to DMSO, there is still selective binding in the imprinted systems for 
Angiotensin II over SVA angiotensin and ADH. The recognition study shows the 
imprinted network was 6% more selective for angiotensin II than SVA angiotensin 
and 7% more selective than ADH. 
 
In recent years the field of molecular imprinting has gained acceptance as a 
major scientific endeavor, and there has been a dramatic increase in the number 
of journal articles published. With the promise of being able to use these systems 
in biotechnology and pharmaceutical applications, various groups have begun 
using several methods to try to imprint larger molecules such as peptides and 
proteins. These have included processes such as radiation-induced graft 
polymerization [4], dry phase separation [5] and surface imprinting [6].  
Unfortunately, there is still no standard in the field that enables uniform 
comparison between imprinted systems.  Ultimately, recognitive polymers can be 
classified by affinity, selectivity and capacity. However, even with the various 
imprinting techniques, very few imprinted systems have produced the results that 
match the association of a protein or enzyme for a particular ligand [7]. The most 
successful imprinted systems have been for small molecules. Mosbach and 
collaborators have reported up to a 99% selectivity for theophylline over caffeine 
[8]. Imprinted networks for proteins and peptides, however, have been met with 
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much less success. A 30% increase in selectivity is still considered on the high 
end. Therefore, the results presented in this study are promising. 
 
4.4 Conclusions 
 
Configurationally imprinted biomimetic recognitive networks with specific 
recognition for the oligopeptide angiotensin II were fabricated. The networks 
showed 28% sensitivity over their nonimprinted controls, and up to 32% 
selectivity over competitive peptides.  
 
Although much research has been done investigating MIPs using small 
molecules as the templates, less emphasis has been placed on larger, more 
complex templates, such as peptides and proteins due to such factors as 
inherent diffusion limitations of larger molecules and the sensitive 
structure/function relationship of peptides and proteins.  Therefore, the results of 
this work are very significant because it shows that it is possible to create a 
recognitive network for an oligopeptide. The selectivity of this network is also 
relatively higher than most literature reports for templates of similar size.  
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4.5 Figures 
 
 
 
 
 
 
Figure 4.1: System Components of Recognitive Networks 
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Figure 4.2: Template Removal Study 
The polymer was washed for 7 days in acetonitrile with 5% acetic acid. A sample 
was taken from each wash, and measured by UV spectroscopy at 215nm to 
determine concentration. The Figure shows ~87% of Template has been 
removed in each case. 
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Figure 4.3: Recognition Studies with Varying Template to Functional 
Monomer Molar Ration 
Recognition studies performed with poly(ethylene glycol-g-acrylamide) networks 
with a 20 mol% crosslinking percentage. Template to functional monomer molar 
ratios were varied between 1:8, 1:16 and 1:32 Figure shows percent of 
angiotensin II that is bound to the recognitive polymer at 3 h. n=3 * p=0.0024  ** 
p=0.01 
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Figure 4.4: Recognition Studies with Varying Crosslinking Percentage 
Recognition studies performed with poly(ethylene glycol-g-acrylamide) networks 
with a 1:8 template to functional monomer molar ratio. Crosslinking percentages 
were varied from 10 mol% to 80 mol% Figure shows percent of angiotensin II 
that is bound to the recognitive polymer at 3 h. n=3  * p=0.015, ** p=0.003, *** 
p=0.012 
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Figure 4.5: Recognition Studies with Various Polymer Formulations 
Recognition studies performed with poly(ethylene glycol-g-acrylamide) networks 
(PA) or pegylated poly(acrylamide-co-methacrylic acid) (PAM) networks, each 
with a 1:8 template to functional monomer molar ratio and a crosslinking 
percentage of 40 mol%. Figure shows percent of angiotensin II that is bound to 
the recognitive polymer at 3 h. n=3  * p=0.012, ** p= 0.0003 
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Figure 4.6: Specific Recognition of Imprinted Polymer 
Recognition studies performed with pegylated poly(acrylamide-co-methacrylic 
acid) (PAM) networks with a 1:8 template to functional monomer molar ratio and 
a crosslinking percentage of 40 mol%. Imprinted polymer was placed in a 1 
mg/ml solution of either angiotensin II (AngII), SVA angiotensin (SVA) or ADH. 
Figure shows percent of peptide that is bound to the recognitive polymer at 3 h. 
n=3 * p= 0.0007, ** p=0.0002 
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Figure 4.7: Specific Recognition of Imprinted and Nonimprinted Polymers 
in PBS 
Recognition studies performed with pegylated poly(acrylamide-co-methacrylic 
acid) (PAM) networks with a 1:8 template to functional monomer molar ratio and 
a crosslinking percentage of 40 mol%. Imprinted polymer was placed in a 1 
mg/ml solution of either angiotensin II (AngII), SVA angiotensin (SVA) or ADH 
and PBS. Figure shows percent of peptide that is bound to the recognitive 
polymer at 3 h. n=3  
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5 CHARACTERIZATION OF NONDEGRADABLE CONFIGURATIONAL 
BIOMIMETIC IMPRINTED POLYMERS SELECTIVE FOR ANGIOTENSIN II 
 
5.1 Introduction 
 
In creating a synthetic system that mimics naturally occurring recognition 
processes it is important to understand how the network structure behaves in 
physiological conditions.  The performances of the CIBP networks, in particular, 
also depend largely on the composition and spatial orientation of the bulk 
structure. Therefore, it is beneficial to investigate and characterize the structure 
and functionality of the networks. Examining details such as the macro-porous, 
micro-porous and non-porous regions of the network, the polymer’s free 
functionalities and its physical response in solution will greatly aid in 
understanding the performance and will ultimately help in optimizing the system. 
Investigating the functional group conversion, the crystalline structure and the 
overall heterogeneity of the network will give insight to the polymers’ 
biocompatibility and long term stability.   
 
Several methods can be used to evaluate the polymer’s structure, function and 
physical response in solution. Namely, the polymers should be analyzed by SEM, 
FTIR and DSC. Finally, the suitability of hydrogels as biomedical materials and 
their performance in a particular application depends to a large extent on its bulk 
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structure.  Therefore the porosity of the polymer networks should be evaluated. 
This can be done by calculating the number-average molecular weight between 
crosslinks 
cM , network mesh size, ξ, crosslinking density, ρx, and the equilibrium 
weight swelling ratio, q, by standard techniques developed in our laboratory. 
 
5.1.1 Scanning Electron Microscopy of Polymers 
 
Scanning electron microscopy (SEM) is a powerful technique that can help 
discern morphological differences between configurationally imprinted polymers 
and the nonimprinted controls. The principal means of transport of angiotensin II 
or template molecules within the recognitive networks is by diffusion through the 
macromolecular structure. Therefore, an understanding and visualization of the 
effective spaces in the porous network could help to control this process.  
 
SEMs are able to achieve visualization of porous networks by using a high 
voltage field emission gun. The electron stream emitted by this gun forms a 
single beam and then focuses on the sample stage. The instrument then passes 
the beam through scan coils. When the beam strikes the surface of the sample, it 
interacts with atoms which in turn emit secondary electrons, primary 
backscattered electrons, Auger electrons and characteristic X-rays. It is the 
secondary electrons that are able to give the surface features of the sample.  
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5.1.2 FTIR Analysis of Imprinted Polymers 
 
Fourier transform infrared spectroscopy (FTIR) can be used to identify chemical 
compounds which are present in polymer structures. In the case of the CIBPs, it 
is important to show that the functional monomer functionalities are present in the 
final polymer network. This information can be used to understand and optimize 
binding sites and overall recognition.    
 
In imprinted networks, FTIR spectroscopy has been used to determine the nature 
of the template-monomer complex for small molecular weight drugs and for 
determining the change in composition of polymers that are templated [1,2]. FTIR 
spectroscopy also has the potential to show the difference between imprinted 
polymer networks without the presence of template and the networks that contain 
bound molecules [3]. 
 
FTIR uses the intrinsic properties of covalent bonds and their thermal energy 
vibrations to provide useful information about the structure and function of 
polymers. The molecular vibrations contain characteristic quantized vibrational 
energy levels that can absorb infrared radiation with energies that correspond to 
vibrational energy level transitions. The bonds of functional groups, such as 
carboxyl and amine groups, absorb infrared radiation at characteristic energies 
and can be easily identified. The most significant portion of the FITR is the 
frequency range from 1200 cm-1 and 600 cm-1. This is known as the fingerprint 
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region of the IR spectrum because small changes in the structure of the molecule 
can significantly impact the location and shape of the absorption peaks in this 
range. By identifying characteristic peaks in this range, the spectrograms can 
provide powerful insight into the overall chemical compounds present in a 
particular sample. 
 
5.1.3 DSC Analysis of Imprinted Polymers 
 
Differential Scanning Calorimetry (DSC) is a technique that measures the 
temperatures and heat flows associated with transitions in various materials as a 
function of time and temperature in a controlled environment. It can provide 
quantitative and qualitative information about the physical and chemical changes 
in the polymeric network. The instrument records endothermic and exothermic 
changes which provide insight into the melting, recrystallization, and 
decomposition of polymers.  In CIBP networks the DSC can provide important 
information about reaction kinetics, conversion of potentially toxic functional 
monomers and glass transition temperatures. These results in turn provide useful 
information about the overall biocompatibility and long-term stability of the 
network.  
 
 
5.2 Materials and Methods 
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5.2.1 Preparation of Imprinted Polymer for SEM 
 
Polymers were prepared for SEM analysis by cutting swollen, wet polymers into 
disks with a 12 mm diameter. One corner of the polymer was then sectioned at a 
45° angle. This was done in order to image the morphology of the inside of the 
polymers and not the surface layer which is smoothed during polymerization 
between two glass plates. The disks were then dried in a vacuum oven at a 
temperature of 35 °C for two days. The disks were then placed on an SEM stage 
and sputter coated with a AU/Pd target for 30 sec. The coating was 
approximately 22 nm thick. The samples were then analyzed by SEM (Hitachi S-
4500 field emission scanning electron microscope) at 10 kV. 
 
5.2.2  Preparation of Imprinted Polymer for FTIR 
 
The polymers were prepared for spectroscopic analysis by crushing the dry 
polymer films to particle sizes ranging from 75-150 μm. A mg of crushed polymer 
was then placed with 150 mg of dry KBr (Sigma-Aldrich, St. Louis Missouri). This 
mixture was then compressed into a pellet. A KBr pellet that did not contain 
polymer was also made as a control. The pellets were then run through a FTIR 
spectrophotometer (Infinity Gold Series Spectrometer, Mattson, Wisconsin). The 
final spectra were obtained using 128 scans with a resolution of 1 cm-1. FTIR 
spectroscopy was run on both the imprinted polymers and the nonimprinted 
controls.  
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5.2.3 Preparation of Imprinted Polymer for DSC 
 
 
The DSC was used to run kinetic studies and determine the glass transition 
temperatures of the recognitive polymers. All of the kinetic studies were run using 
the TA 90 differential scanning calorimeter as a miniature reactor (TA 
instruments, New Castle, Delaware).  A diagram of the experimental setup can 
be seen in Figure 5.1.  First, approximately 4.5 to 6.0 mg of the monomer sample 
was weighed using a digital scale and pipetted into a small aluminum pan using a 
volumetric pipette.  The volume of sample added was approximately 3 μL. The 
sample pan was then sealed with a piece of polyethylene and placed into the 
calorimeter.  An empty aluminum reference pan was sealed with polyethylene 
and placed beside it.   
 
Before the monomer was initiated, the atmosphere was made inert by purging 
the system with nitrogen gas at a pressure of 20 psia for 20 minutes.  Then, UV 
light with an intensity of 1.0 mW/cm2 was applied to the system for 699 seconds.  
The heat produced by the reaction with reference to the empty pan was collected 
over the period of time.  Three data points were collected for each second of 
passing time.   
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For the glass transition experiments, approximately 5 mg of polymer sample was 
placed into an aluminum pan. The pan was then sealed and crimped with an 
aluminum lid. The pan was placed into the calorimeter and a reference pan was 
placed beside it. The atmosphere was then made inert by purging with nitrogen 
gas. The DSC scans were started at 30 °C and increased to 120 °C at a rate of 
10 °C/min. 
 
All DSC scans were run using four different formulations of polymers that were 
previously determined to show the best recognition. The four different 
formulations were divided into two sets of polymers, poly(ethylene glycol)-g-
acrylamide (PA) and pegylated poly(acrylamide-co-methacrylic acid) (PAM).  
Within each set of two polymers, an imprinted polymer which contained 
Angiotensin II as a template and a control polymer which did not contain the 
template molecule were made. The polymers all contained a crosslinker 
percentage of 40 mol% and a template to functional monomer molar ratio of 1:8. 
  
5.3 Results and Discussion 
 
5.3.1 SEM Analysis of Imprinted Polymers 
 
Imprinted and nonimprinted polymer networks were prepared and analyzed by 
scanning electron microscopy.  SEM micrographs of both the imprinted polymers 
and the non imprinted controls can be seen in Figures 5.2 and 5.3. The polymer 
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formulations are pegylated poly(acrylamide-co-methacrylic acid) with a 
crosslinker percentage of 40 mol% and a template to functional monomer molar 
ratio of 1:8. Figure 5.2 was taken on the Hitachi S-4500 field emission scanning 
electron microscope. Figure 5.3 was taken on a LEO 1530 scanning electron 
microscope at a slightly lower magnification of 40.88K x.  The results clearly 
show a morphological difference between the imprinted and non-imprinted 
polymers. In Figure 5.2 the imprinted polymer is seen having a greater amount of 
pores and disorganized striations. The pores range from 10-150 nm. In figure 5.3 
there is a distinct surface roughness change with the imprinted polymer having a 
much more varied roughness.  The peaks on the surface of the imprinted 
polymers are located approximately 80 nm apart. These peaks cannot be seen 
on the non-imprinted controls. 
 
Due to the addition of a template molecule in the imprinted network, one would 
assume that the imprinted networks would be more porous. This is in part 
because the functional monomers interact with the template forming cavities 
around it.  In fact, there are several reports in the literature that show 
morphological differences between imprinted and non-imprinted networks [4, 5]. 
Spizzirri et al. were the first to calculate nanocavitiy size in imprinted networks. It 
was concluded from these studies that cholesterol imprinting left a size of 15-37 
Ả. However, it was also noted that higher template loading and the use of 
porogens could affect the microporosity and lead to higher pore sizes. In the 
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case of angiotensin II, however, the hydrodynamic radius is estimated to be less 
that 1 nm [6]. This size would not be seen in a typical SEM micrograph, indicating 
that there are other interactions that are contributing to the more porous network. 
In particular, acrylamide is known to form polymer loops upon crosslinking when 
in the presence of a hydrophilic moiety [7]. The template molecule angiotensin II 
could be considered as such a moiety, as it is a hydrophilic peptide.   
 
The visible nanocavities could also be formed due to polymer/template 
thermodynamic interactions. In short, the solubility of the template angiotensin II 
in the prepolymerization mixture is not considered perfectly soluble. Therefore, 
the cavities are often formed by several dissolved template molecules [5]. 
 
In the end, the imprinted networks did show significant morphological differences 
which could ultimately have an effect on the overall recognition process.  The 
selective binding therefore becomes a complex process with both interactions 
with free functionalities from the functional monomers and the effects of size 
exclusion and diffusion through the networks.  
 
5.3.2 FTIR Spectroscopic Analysis of Imprinted Polymers 
 
FTIR spectroscopy was used in order to analyze the molecular structure of the 
novel imprinted polymers. This technique allowed not only the molecular 
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structure of the imprinted network to be probed but also addressed possible 
template-imprinted polymer interactions. The FTIR spectrogram of a pegylated 
poly(acrylamide-co-methacrylic acid) with a crosslinker percentage of 40 mol% 
and a template to functional monomer molar ratio of 1:8 can be seen in Figure 
5.4. This spectrogram shows that the free functionalities of the functional 
monomers are present in the final network instead and have not only interacted 
with each other.  
 
In order to determine that the imprinted polymer contained the acrylamide and 
methacrylic acid functionality, several peaks should be present. For the 
acrylamide, in particular, the spectra should show a strong absorption peak at 
1673 cm-1 (C=O) stretch and its shoulder peak at 1615 cm-1 (N-H bending) [8]. 
These can be seen in Figure 5.4. The methacrylic acid functionality exhibits a 
peak at 1421 cm-1. This corresponds to the symmetric stretching of the C=O 
bond of the bound carboxylic acid group.  The peak at 1649 cm-1 represents the 
C=O stretching of the free carboxylic acid groups, meaning those with the 
hydroxyl group still intact.  The intensity of this peak is much lower than that of 
the bound carboxylic acid peak, indicating that majority of the methacrylic acid 
monomers have self-reacted during polymerization [9]. Ultimately, however, both 
functionalities are still present in the final network which allows for the hydrogen 
and ionic bonding of several groups in the angiotensin II template.  
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5.3.3 Thermal and Kinetic  Analysis of Imprinted Polymers 
 
A powerful method of analyzing imprinted structures involves measuring the 
kinetic data of the polymerization reaction in the presence or absence of a 
template molecule [10, 11]. Thermal analysis was therefore used to collect kinetic 
data. Both the conversion of the monomer into polymer and the rate of 
polymerization at each point in the reaction were calculated. This was done for 
the polymerization reactions both with and without the presence of the template.  
The rate of polymerization, or Rp, was calculated by the theoretical heat of 
conversion using equation 5.1.  In equation 5.1, it was assumed that the amount 
of heat that would be released from PEGMA 100 and PEGDMA 1000 would be 
13.6 kcal/mol [12]. The heat of reaction of all methacrylate derivatives can be 
approximated using this number, which is also the energy necessary to react a 
double bond.  The heat of reaction of acrylamide was approximated to be 18.9 
kcal/mol [12]. The theoretical heat of reaction was found according to equation 
5.1, where ΔHT is the theoretical heat of reaction, ΔΗ  is the heat of reaction, x is 
the sample mass and mwp is the molecular weight of the polymer.  
 
)component  offraction  mole
mw
1x   H Σ(H
p
T ⋅⋅⋅Δ=Δ   (5.1) 
 
 
Then, the rate of polymerization was calculated using equation 5.2. 
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H
W
Δ=pR                          (5.2) 
 
  
After the rate of polymerization was calculated at each of the data points, the 
conversions at each of the data points and overall were calculated.  The 
integrated area under the rate of polymerization curve is conversion.  Because 
the data points were taken at such small time intervals, the area under the curve 
was approximated using rectangles, as seen in equation 5.3 where the subscript 
j represents each data point. 
( )( )∑
=
++ ⎟⎠
⎞⎜⎝
⎛+−=
n
1j
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1RRtimetimeconversion              (5.3) 
 
 
 
Both the shapes and the heights of the curves for the rates of polymerizations of 
the four samples were similar.  Figure 5.5 is a graph of each sample’s rate of 
polymerization as function of time.  As seen in the graph, the PAM samples 
yielded slightly higher maximum rates of polymerization.  The difference in the 
maximum rate of polymerizations between the PAM control and the PAM test 
sample was 3.6% with the control being slightly lower.  The PA samples yielded 
slightly lower maximum rates of polymerization.  However, the PA control had a 
maximum rate of polymerization slightly higher than the test sample by 13.5%.   
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It was also determined that conversions between the polymer control samples 
and their respective samples with template were similar.  The conversions for the 
control samples were slightly higher; there was a 7.5% difference in conversions 
between the PAM control and the PAM test sample and a 6.9% difference in 
conversions between the PA control and the PA test sample.  Figure 5.6 is a 
graph of the overall conversions for the four polymers.     
 
The kinetics of the polymerization reactions were analyzed in order to determine 
the overall conversion of the potentially toxic monomers and to examine the 
effect of the template on the polymerization reaction. The results clearly show 
that the imprinted networks do not achieve as high of a conversion as the control 
samples due to the presence of the template. This is a similar conclusion to a 
trend observed by Ward et al [10].  
 
5.3.4 Structural Analysis using Thermal Studies 
 
DSC studies were used to determine the glass transition temperature, Tg, which 
can be used to analyze the molecular structure. The DSC scans were run to 
collect kinetic data, and thermograms were collected to determine Tg values. The 
Tg values of the polymer formulations were determined by using the tangent lines 
at the onset and end of the transition using the half Cp method, giving a Tg value 
that corresponds to the middle of this energy transition. Figure 5.6 shows an 
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example of a thermogram of a poly(ethylene glycol)-g-acrylamide-g-methacrylic 
acid with a 1:8 template to functional monomer ratio and 40% crosslinker.  
 
The value of the Tg for a polymer is important because it affects the mechanical 
properties at particular temperatures and determines the temperature range in 
which a material can be used effectively. Several factors affect the Tg. Bond 
interaction, molecular weight, functionality, branching and chemical structures 
are all important in determining Tg. It is possible to calculate a theoretical Tg by 
using equation 5.4 
 
...++=∞ gyygxxg TwTwT      (5.4) 
 
Tg values were calculated using equation 5.4 which relates the Tg of an ideal 
blend (Tg∞ ) to the Tg values of their constituent linear polymers [13, 14]. 
 
In this equation, Tg∞ represents the glass transition temperature of an equivalent 
linear copolymer which would be observed if all crosslinks in the polymer system 
were severed. Wx and wy represent the weight fractions of the respective 
constituent linear polymers such as poly(acrylamide), poly(methacrylic acid) and 
PEG. The weight fractions can be easily calculated based on the molar feed 
concentrations of the comonomers. The Tg values of each of the constituents 
were based on literature reports. 
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Table 5.1 summarizes the results for the molecularly imprinted and the control 
structures studied.  The experimental values correlate well with the theoretical 
values. It can also be seen that the glass transition temperatures of the imprinted 
networks are not significantly different than the non-imprinted network. This 
suggests that the template does not affect the overall crystalline structure.  
 
This is a significant finding which indicates that the crosslinked structure remains 
the same in the presence and absence of the template, suggesting that the 
template does not affect the crosslinking process.  Since the template molecules 
do occupy some of the nanocavity space, this space is simply the “mesh size” of 
the imprinted networks. This is important in that it supports the idea of calculating 
the nanocavity size for measurements of the number average molecular weight 
between crosslinks, 
cM . 
 
5.3.5 Bulk Structure Analysis of Imprinted Polymers 
 
 
The suitability of hydrogels as biomedical materials and their performance in a 
particular application depends to a large extent on their bulk structure. As shown 
by Spizzirri and Peppas [5], the nanocavity structure can be determined from the 
calculation of the value of 
cM and the associated mesh size, ξ. Thus, the 
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number-average molecular weight between crosslinks 
cM , network mesh size ξ, 
crosslinking density, ρx, and equilibrium weight swelling ratio, q,  were calculated 
using the procedure described  below. 
 
The change of chemical potential due to the elastic retractive forces of the 
polymer chains can be determined from the theory of rubber elasticity.  Upon 
equaling the Gibbs free energy of the elastic contribution to the Gibbs free 
energy of the polymer/solvent thermodynamic interactions, as described by the 
Flory-Huggins Theory, an expression for determining the molecular weight 
between two adjacent crosslinks,  M c, of an imprinted hydrogel prepared in the 
absence of a solvent was written as: 
 
 
1
M c
= 2
M n
−
υ 
V1
⎛ 
⎝ ⎜ 
⎞ 
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⎞ 
⎠ ⎟ 
    (5.5) 
 
Here,   M n, is the molecular weight of the polymer chains prepared under 
identical conditions but in the absence of the crosslinking agent, υ  is the specific 
volume of the polymer and V1 is the molar volume of water.  Although the 
polymer was originally prepared in DMSO, this is an appropriate approximation 
due to the thermodynamic properties at room temperature [15]. The Flory 
polymer-solvent interaction parameter, χ, was calculated as a weighted average 
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of the values for PMAA (χ = 0.5987) and PEG (χ = 0.55) in water. Such 
averaging procedures are not usually acceptable in polymer thermodynamics, 
but are very appropriate here because of the similarity of the parameter values 
under the conditions of operation [5].  
 
It was then possible to use the modified version of the original Flory-Rehner 
theory for hydrogels prepared in the presence of water.  The presence of water 
effectively modified the change of chemical potential due to the elastic forces.  
This term must now account for the volume fraction density of the chains during 
crosslinking.  The resulting Peppas-Merrill equation (equation (5.6)) can be used 
to determine the molecular weight between crosslinks in a imprinted hydrogel 
prepared in the presence of water. 
 
1
M c
= 2
M n
−
υ 
V1
⎛ 
⎝ ⎜ 
⎞ 
⎠ ⎟ ln 1−υ2,s( )+υ2,s + χ1υ2,s2[ ]
υ2,r υ2,sυ2,r
⎛ 
⎝ 
⎜ ⎜ 
⎞ 
⎠ 
⎟ ⎟ 
1
3
− υ2,s
2υ2,r
⎛ 
⎝ 
⎜ ⎜ 
⎞ 
⎠ 
⎟ ⎟ 
⎡ 
⎣ 
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⎤ 
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    (5.6) 
Here, υ2,r is the polymer volume fraction in the relaxed state, which is defined as 
the state of the polymer immediately after crosslinking but before swelling. 
 
An important structural parameter to analyze hydrogels is the amount of space 
available between macromolecular chains.  This space is often regarded as the 
molecular mesh. Depending upon the size of these nanosized pores hydrogels 
can be conveniently classified as (i) macroporous (ii) microporous and (iii) 
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nonporous. A structural parameter that is often used in describing the size of the 
pores is the correlation length, ξ, which is defined as the linear distance between 
two adjacent crosslinks and can be calculated using the following equation: 
 
 
  
ξ = α r o2( )1 2          (5.7) 
Here, α is the elongation ratio of the polymer chains in any direction and 
  
r o
2( )1 2  is 
the root-mean-square, unperturbed, end-to-end distance of the polymer chains 
between two neighboring crosslinks. For an isotropically swollen hydrogel, the 
elongation ratio, α, can be related to the swollen polymer volume fraction, υ2,s, 
using equation (5.8). 
 
   α = υ2,s
−1 3          (5.8) 
 
The unperturbed end-to-end distance of the polymer chain between two adjacent 
crosslinks can be calculated using equation (5.9), where Cn is the Flory 
characteristic ratio (Cn, PMAA= 14.6 and Cn, PEG = 3.8 [16]), l is the length of the 
bond along the polymer backbone (for acrylic polymers 1.54 A) and N is the 
number of links per chain that can be calculated by equation (5.10).  
 
  
r o
2( )1 2 = l CnN( )1 2         (5.9) 
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N = 2M c
Mr
         (5.10) 
In equation (5.10), Mr is the molecular weight of the repeating units from which 
the polymer chain is composed.  Finally, when one combines equations (5.7) 
through (5.10), the correlation distance between two adjacent crosslinks in a 
swollen hydrogel can be obtained: 
 
 
  
ξ = υ2,s−1 3 2CnM cMr
⎛ 
⎝ ⎜ 
⎞ 
⎠ ⎟ 
1 2
l        (5.11) 
 
The bulk structure characteristics are summarized in Table 5.2.  The mesh size 
of the polymer is approximately 13 Å. The hydrodynamic radius of angiotensin II 
is estimated to be less that 1 nm [6] which is less than 10 Å. Therefore, the 
template molecule should be able to move throughout the network without much 
hindrance. 
 
5.4 Conclusions 
 
 
Spectroscopic analysis and structural investigation provided important 
information about the imprinted networks and the effects that the polymerization 
process has on them.  Most significantly, the presence of a template during the 
polymerization process has negligible effects on the conversion of the functional 
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monomers and the crosslinking process. This is important because unconverted 
monomer can have future effects on the cytotoxicity of the gel. The 
polymerization process also did not affect the presence of free functionalities of 
the functional monomers in the final network. FTIR spectroscopy was able to 
confirm that all functionalities were present in the final gel form.   
 
Although the polymerization process was basically unaffected by the presence of 
a template molecule, the overall morphology of the imprinted network was. SEM 
micrographs showed significant morphological differences between the imprinted 
polymers and the non-imprinted controls.  This is consistent with previous work 
by Spizzirri et al. [5] which suggests that this is due to polymer/template 
thermodynamic interactions. In this case the template is not completely soluble 
and can form aggregates which increase the pore size in the networks.  
 
Ultimately the results of this work provide useful information about the general 
biocompatibility and long-term stability of the network. They also provide valuable 
insight to the function of the network which can be beneficial for optimizing the 
overall recognition process.  
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5.5 Figures 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1: DSC Experimental Apparatus  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
79
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2: SEM analysis  
SEM analysis of pegylated poly(acrylamide-co-methacrylic acid) (PAM) networks 
with a 1:8 template to functional monomer molar ratio and a crosslinking 
percentage of 40 mol% (top) and control non-imprinted polymer (bottom). Pore 
sizes of imprinted networks are 10-150 nm. Scale bar = 3.00μm 
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Figure 5.3: SEM analysis  
SEM analysis of pegylated poly(acrylamide-co-methacrylic acid) (PAM) networks 
with a 1:8 template to functional monomer molar ratio and a crosslinking 
percentage of 40 mol (top) and control non-imprinted polymer (bottom). 
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Figure 5.4: FTIR spectrum of CIBP  
FTIR spectra of pegylated poly(acrylamide-co-methacrylic acid) (PAM) networks 
with a 1:8 template to functional monomer molar ratio and a crosslinking 
percentage of 40 mol%. 
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Figure 5.5: Rates of Polymerization versus Time 
Samples of pegylated poly(acrylamide-co-methacrylic acid) (PAM) networks with 
a 1:8 template to functional monomer molar ratio and a crosslinking percentage 
of 40 mol%, poly(ethylene glycol-g-acrylamide) (PA) networks with a a 1:8 
template to functional monomer molar ratio and a crosslinking percentage of 40 
mol% and their nonimprinted controls. 
 
 
 
 
 
 
 
 
 
83
 
 
 
 
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
PAM Control PAM PA Control PA
Polymer Sample
C
on
ve
rs
io
n
 
Figure 5.6: Overall Conversions  
Samples included pegylated poly(acrylamide-co-methacrylic acid) (PAM) 
networks with a 1:8 template to functional monomer molar ratio and a 
crosslinking percentage of 40 mol%, poly(ethylene glycol-g-acrylamide) (PA) 
networks with a  1:8 template to functional monomer molar ratio and a 
crosslinking percentage of 40 mol% and their nonimprinted controls. 
 
 
  
 
 
 
 
 
 
84
 
 
 
 
 
-0.45
-0.4
-0.35
-0.3
-0.25
-0.2
-0.15
-0.1
-0.05
0
25 45 65 85 105
C
W
/g mW/mg
 
Figure 5.7: Thermogram of Poly(ethylene glycol)-g-acrylamide-g-
methacrylic acid imprinted polymer 
Tg is 71.62 °C 
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Table 5.1: Observed and Theoretical Tg of Polymer Formulations 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Polymer Formulation Tg, observed °C Tg, theoretical °C 
P(EGMA 400) n/a -59 
P(Aam) n/a 165 
P(MAA) n/a 228 
P(EGDMA 1000) n/a 141 
PA control 68 58.44 
PA imprinted 67.88 55.7 
PAM control 73.13 81.95 
PAM imprinted 71.62 77 
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Table 5.2: Bulk Structure Characteristics 
 
 
Polymer 
Equilibrium 
Polymer Vol 
Fraction, υ2,s 
Molecular 
Weight 
Between 
Crosslinks,
cM  
(g·mol-1) 
Mesh size,  ξ 
(Å) 
Equilibrium 
weight 
swelling ratio, 
q 
PA Control 0.443 103.548 12.57 3.8 
PA Imprinted 0.441 94.687 12.67 2.88 
PAM Control 0.229 112.41 12.89 3.5 
PAM Imprinted 0.215 125.581 13.59 2.56 
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6  FABRICATION AND CHARACTERIZATION OF DEGRADABLE 
CONFIGURATIONAL BIOMIMETIC IMPRINTED POLYMERS SELECTIVE FOR 
ANGIOTENSIN II 
 
 
6.1 Introduction 
 
Although significant advances have been made in molecularly imprinted 
networks during the past two decades, there has not been much development of 
them for use in the drug delivery field. This is in part due to the fact that in order 
to successfully use MIPs for many applications in pharmaceutical treatments, 
DDS and tissue engineering constructs, the networks themselves need to have a 
biodegradable component.  Having the constructs or devices degrade allows for 
sustained release of drug and complete removal of the foreign object from the 
physiological environment without the need for further invasive procedures.  
 
Several biodegradable materials have been studied extensively for their use in 
biomedical applications such as temporary tissue scaffolds, barriers for surgical 
adhesions and matrices for DDS [1-7]. These materials can usually be classified 
into three categories of degradation: solubilization, enzyme catalysis and/or 
chemical hydrolysis [8]. In all of these cases it is important that the polymer 
constructs have the appropriate water permeability, biocompatibility and tensile 
strength. It would also be ideal if the polymer left no residual polymer after 
degradation and no toxic by-products [7]. For many devices it is important that 
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the degradation rate be tuned and adjusted to the requirements of the 
application.  
 
Perhaps, the most common synthetic biodegradable polymers that are being 
investigated are poly(α-hydroxy esters), including poly(glycolic acid) (PGA), 
poly(lactic acid) (PLA), their copolymer poly(lactic-co-glycolic acid) (PLGA) and 
poly(ε−capralactone) [9]. Primarily, this is because they are FDA approved and 
already clinically used. They are considered biocompatible and their degradation 
products are not cytotoxic. PLA and PGA also can be easily processed and their 
degradation rates and physical and mechanical properties can be adjusted over 
a wide range simply by using various molecular weights and copolymers. The 
chemical properties of poly(α-hydroxy esters) allow hydrolytic degradation 
through de-esterification. Once degraded, the monomeric components of each 
polymer can be removed by natural pathways. In fact, the body already has 
highly regulated mechanisms for completely removing the monomeric 
components of lactic and glycolic acid [10]. 
 
In configurationally imprinted biomimetic polymers that recognize peptides and 
proteins, the poly(α-hydroxy ester) degradable components can also potentially 
degrade or denature proteins or peptides which are entrapped in the network. 
This depends, however, on the degree of crosslinking and the amount of acid 
available.  This process can take place because many amino acid chains are 
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acid labile. Therefore, in a microenvironment, such as a recognitive network 
where the peptide or protein is bound, the acidic by-products of poly(α-hydroxy 
esters) can have catastrophic effects on the peptide by cleaving it and rendering 
it inactive and unable to interact with its receptors. This can be an advantageous 
side effect when it is desirable to remove excess proteins or peptides from the 
body. Situations like this occur when the body upregulates the particular protein 
and it becomes over-expressed. Systems that are capable of achieving this effect 
could become part of a whole new generation of therapeutic systems. 
 
It was, therefore, a goal of this work to incorporate a poly(α-hydroxy ester) 
degradable crosslinker into the recognitive network. By only replacing the 
crosslinker, and replacing the crosslinker with a structurally similar one, it was 
hoped that the new recognitive network would show very little compromise to the 
original recognition abilities of the nondegradable network. Ultimately, this new 
system would also allow for a more biocompatible system that is easily cleared 
from the body and possibly provide for a novel drug delivery device by being able 
to destroy bound oligopeptides. 
 
6.2 Materials and Methods 
 
6.2.1 Preparation of Hydrolytically Cleavable Poly(α-hydroxy ester) 
Crosslinkers. 
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Poly(α-hydroxy ester) crosslinkers were synthesized according to a method 
originally described by Sawhney et al. [10] In a characteristic experiment, 30 g of 
dry α,ω-dihydroxy PEG 1000 (Sigma-Aldrich, St. Louis, Missouri), 3.6 g of 
glycolide  (E. I. du Pont de Nemours) and 15 mg stannous octoate (Sigma-
Aldrich, St. Louis, Missouri) were charged into a round-bottomed flask under a 
nitrogen atmosphere. The mixture was then stirred under vacuum at room 
temperature for 1 hour. It was then heated to 160°C under nitrogen for 16 hours 
and finally allowed to cool to room temperature. In order to switch between 
nitrogen and vacuum a dual bank manifold was used (Figure 6.1). The copolymer 
that was created was dissolved in dichloromethane, precipitated in anhydrous 
ether and dried.  
 
The pegylated poly(glycolic acid) was then end-capped with acrylate groups in 
order to form a photopolymerizable polymer. This was synthesized by dissolving 
30 g of pegylated poly(glycolic acid) in 300ml of dichloromethane. The mixture 
was then cooled to 0°C. While maintaining that temperature, 1.30 ml of 
triethylamine and 1.58 ml of acryloyl chloride (Sigma-Aldrich, St. Louis, Missouri) 
was added. This was then stirred for 12 hours at 0°C and 12 hours at room 
temperature. The mixture was filtered to remove triethanolamine hydrochloride. 
The macromer was ultimately captured by pouring the filtrate in dry diethyl ether. 
This was finally purified by dissolution and reprecipitation using dichloromethane 
and hexane. It was then dried under vacuum at 70°C. 
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The final product of this synthesis produces a pegylated poly(glycolic acid) 
diacrylate macromer which can act as a crosslinker and be photopolymerized 
into a polymer. This can then be hydrolytically cleaved and degrade into PEG, 
glycolic acid and poly(acrylic acid). The overall reaction scheme of this synthesis 
can be seen in Figure 6.2. 
 
 
6.2.2 Preparation of Pegylated Poly(glycolic acid)  Diacrylate 
Macromers for FTIR Analysis 
 
 
FTIR spectroscopy was conducted in order to characterize the macromers. The 
FTIR pellets were prepared by crushing the dry macromers at all stages of 
synthesis and purification to particle sizes ranging from 75-150 μm. A sample of 
1 mg of crushed macromer was then placed with 150 mg of dry KBr (Sigma-
Aldrich, St. Louis Missouri). This mixture was then compressed into a pellet. The 
final PGA-PEG-PGA diacrylate macromer was waxy and could not be crushed. It 
was, therefore, dissolved in dichloromethane and added dropwise with a Pasteur 
pipette into 150 mg of dry KBr. The KBr/macromer mixture was then mixed and 
allowed to dry in a 70°C vacuum oven overnight. A KBr pellet that did not contain 
macromer was also made as a control. Pellets were also made for the original 
α,ω-dihydroxy PEG 1000 for comparison. The pellets were then run through a 
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FTIR spectrophotometer (Infinity Gold Series Spectrometer, Mattson, Wisconsin). 
The final spectra were obtained using 128 scans with a resolution of 1 cm-1.  
 
 
6.2.3 Synthesis of Degradable Imprinted Polymer 
 
The newly synthesized PGA-PEG-PGA 1000 diacrylate was used as a 
degradable crosslinker and substituted for the poly(ethylene glycol) 1000 
dimethacrylate crosslinker in the nondegradable network. The recognitive 
polymers were then prepared in an identical way to the nondegradable systems. 
The most recognitive nondegradable network formulation was used for the 
degradable systems. This was poly(ethylene glycol) grafted poly(acrylamide-co-
methacrylic acid) with a crosslinker percentage of 40 mol% and a template to 
functional monomer ratio of 1:8.   
 
Briefly 0.095g of (PEGMA 400) (Polysciences Warrington, PA.), 0.15 g of 
methacrylic acid (MAA), and 0.13 g of acrylamide (AAm) (Sigma-Aldrich, St. 
Louis Missouri) were placed in an amber bottle and dissolved in 0.6707 g DMSO 
(Fisher Scientific). The monomers were in a 1:1:1 molar feed ratio of ethylene 
glycol units:AAm:MAA.  Then, 0.043 g of angiotensin II was added. The solution 
was allowed to sit for 20 minutes in order to form prepolymerization complexes. A 
sample of 0.2255 g of pegylated poly(glycolic acid) 1000 diacrylate crosslinker 
 
96
was then added. After the monomer solution was mixed and allowed to go into 
solution, the photoinitiator 1-hydroxyclyclohexyl phenyl ketone (Irgacure 184®) 
(CIBA-GEIGY Hawthorne, NY) was added.  
 
The amber bottle was then covered with parafilm and placed in a nitrogen 
atmosphere. A needle was placed through the parafilm and nitrogen was allowed 
to bubble through the solution for 20 minutes in order to remove the oxygen, a 
free-radical scavenger. The solution was then pipetted between two glass plates 
which were separated by a 700 μm Teflon spacer. The glass plates were then 
exposed to UV light (Dymax 2000_EC Light Curing System, Torrington, CT) for 
20 minutes at an intensity of 16 mW/cm2. The resulting polymer was then 
removed from the glass plates and washed in a 300ml solution of acetonitrile with 
5% acetic acid for 7 days. This was to ensure template extraction and the 
removal of any unreacted monomer.  The polymer was then dried in a vacuum 
oven at 35°C for 2 days. It could then be cut into 12 mm diameter disks or 
crushed into particles ranging in size from 75-150 μm. Control polymers were 
synthesized in the same manner with the exception that no angiotensin II was 
added.  
 
6.2.4 Recognition Studies of Degradable Imprinted Polymer 
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To determine if angiotensin II was successfully imprinted into the polymer 
networks, recognition studies were performed. The polymer was placed in the 
presence of angiotensin II and SVA angiotensin. SVA angiotensin is a 
synthesized derivative of angiotensin II in which three amino acid moieties were 
substituted. Its structure is ser-arg-val-tyr-val-his-pro-ala. It has a molecular 
weight of 958 and a charge at pH 7 of +1. Both of these characteristics are 
similar to angiotensin II. The binding studies were also conducted in both DMSO, 
the solvent used during the synthesis, and phosphate buffered solution (PBS) 
with a pH of 7.4. The latter was used to simulate physiological conditions.  
  
In a typical experiment, dry imprinted polymers were cut into 12 mm diameter 
disks and weighed. A disk was then placed into a 15 ml conical tube which had 
either solutions of 1 mg/ml angiotensin II in DMSO, 1 mg/ml angiotensin II in 
PBS, 1 mg/ml SVA angiotensin in DMSO or 1 mg/ml SVA angiotensin in PBS. 
Nonimprinted control polymers of the same formulation were also cut into 12 mm 
disks, and placed into their own 15 ml conical tubes containing the solutions 
described above. The tubes were then placed on a rotating mixer set at 25 rpm. 
At time points of 0, 1, 2, and 3 hours, three 200 μl samples of supernatant were 
removed and placed into a UV/Vis 96-well plate. The plates were then read by a 
UV/Vis microplate reader at a wavelength of 215 nm. The results were then 
compared to standard curves of known concentration of both angiotensin II and 
SVA angiotensin. From this the peptide concentration in the supernatant was 
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determined. This concentration was then subtracted from the original solution 
concentration. The final result was then divided by the weight of the original dry 
polymer to determine mg bound/mg polymer. All experiments were repeated in 
triplicate for each formulation of the polymer.  
 
The degradable polymer construct was then tested for specific recognition 
against a physiologically relevant peptide. The binding studies were performed 
as previously described; however, instead of using SVA angiotensin, a 
synthesized peptide which is also present in the blood stream, antidiuretic 
hormone (ADH) was used.  
 
6.2.5 In Vitro Degradation 
 
To measure the degradation rates of the degradable construct, imprinted and 
non-imprinted polymers were cut into 12 mm diameter disks and dried in a 
vacuum oven for 24 hours. The disks were then equilibrated in 100 ml of PBS at 
pH 7.4. The disks were then weighed to determine the initial polymer weight. The 
polymers were returned to the PBS, placed on a shaker plate and incubated at 
37°C. Weight loss was measured gravimetrically each day for a period of 3 
weeks.  
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6.2.6 Gel Permeation Chromatography of Degraded Polymers 
 
Degradation products of the degradable polymers were measured by gel 
permeation chromatography (GPC) in order to determine their molecular weight.  
In physiological conditions, the molecular weight of the degradation products can 
influence the body’s immune response and determine whether it can be cleared 
by the RES. Therefore, imprinted and non-imprinted polymers with PGA-PEG-
PGA diacrylate macromers incorporated as their backbone were allowed to 
degrade in PBS at 37°C.  The solution was then placed in a rotary evaporator in 
order to remove excess liquid and concentrate the polymer degradation products. 
A sample of 50 μl of the concentrated solution was then injected into an Alliance 
GPC (Waters, Milford MA). A sample containing only the solvent PBS was also 
run for elution peak comparison. Elution time was then recorded and molecular 
weight determined.  
 
6.2.7 Placement  of Angiotensin II in Degradable Conditions 
 
It is the hypothesis that when a biodegradable component is added to the 
imprinted system, the acid that accumulates during degradation will have a 
catastrophic effect on the recognized peptide. Therefore, the following set of 
experiments was run to determine the extent to which angiotensin II could be 
cleaved by acid hydrolysis. 100 μg of angiotensin II were placed into 100 μl of 
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various acids. The acids included 70% lactic acid, 85% lactic acid, 6N HCl, 70% 
formic acid, 70% THF and 70% glycolic acid.  These solutions were then 
incubated at either 37°C or 70°C for 24 hours. After the incubation period, the 
samples were run on an electrospray ionization (ESI) mass spectrometer. For 
comparison, a sample of 1 μg angiotensin II/1 μl H2O was also run through ESI.  
 
6.3 Results and Discussion 
 
6.3.1 FTIR Analysis of Synthesized Crosslinker 
 
FTIR spectroscopy was conducted at various stages of the synthesis of the new 
crosslinker in order to ensure the soundness and accuracy of the structure.  A 
spectrogram of the original α,ω-dihydroxy PEG 1000 precursor can be seen in 
figure 6.3. The key peaks of the pure PEG that can be seen are the 2880 cm-1 
due to the C-H stretch, an 1110 cm-1 due to the ether stretch and the 
absorbance at 3510 cm-1 due to the terminal hydroxyl group. After the addition of 
the poly(glycolic acid) groups, a FTIR spectrogram should show an additional 
absorbance peak at 1756 cm-1. This shows the presence of an ester stretch due 
to glycolidyl moieties. This is seen in Figure 6.4.  Finally, it is the free terminal 
hydroxyl group that reacts with the acrylate groups during acrylation. Therefore, 
after the addition of acrylate groups to the pegylated poly(glycolic acid), there 
should be a loss of absorption at 3510 cm-1 [11]. This can be seen in Figure 6.5. 
Ultimately, a purified poly(α-hydroxy ester) crosslinker spectrogram should show 
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strong absorbance peaks in the ester stretch, the ether stretch and the C-H 
stretch. The presence of all of these peaks in Figure 6.5 ensures that the 
crosslinker was successfully synthesized and that the chemical structure is 
sound.  
 
6.3.2 Recognition Analysis of Degradable Imprinted Polymer 
 
After the incorporation of the synthesized crosslinker into the recognitive network, 
the newly formed degradable CIBPs were compared to the nondegradable 
networks. The polymers were visually compared and recognition studies were 
performed to ensure that the recognitive abilities of the system were still intact. 
Upon visual inspection the polymer networks appeared relatively similar with both 
gels being fairly transparent.  
 
Of greater importance than the comparison of gels’ visual appearances was the 
comparison of their recognitive abilities. Recognition studies were, therefore, 
performed on the degradable network. The imprinted polymer was compared 
both to its non-imprinted control and the competitive peptides SVA angiotensin 
and the biologically relevant ADH for specific recognition. The results of these 
studies are shown in Figure 6.6.  
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The degradable network, compared to the nondegradable network, showed very 
little loss in recognition capabilities.  Although is showed slightly less specific 
recognition of angiotensin II versus its competitive peptides, it was approximately 
23% more selective for angiotensin II than SVA angiotensin, and approximately 
28% more selective for angiotensin II than ADH. Part of the reason for loss of 
specificity could be due to the fact that the crosslinker is slightly bulkier than its 
nondegradable counterpart. It could, therefore, be possible to increase this 
recognition by shortening the length of the original PEG precursor. However, 
although this specificity is less than the nondegradable polymer, it still 
demonstrates that it is possible to add a degradable component to the system 
and maintain recognition.  A selectivity of over 20% for an oligopeptide is also 
considered relatively high when compared to the findings reported in the current 
literature [12]. 
 
The main difference between the degradable and nondegradable network was 
that when it was compared to its nonimprinted control the degradable polymer 
was approximately 17% more selective for angiotensin II. This was significantly 
less than the 26% seen in the nondegradable network. The result implies that the 
network is binding to molecules based on nonspecific interactions. A possible 
explanation for this is that the gel contains an excess of free functionalities. 
Again, if the degradable crosslinker was not fully acrylated with double bonds on 
each side of its chains, a terminal free hydroxyl group would remain at the end of 
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the poly(glycolic acid) chain. This hydroxyl group would be free to interact with 
molecules because the chain would be grafted into the polymer instead of 
crosslinked. Ultimately this would lead to more hydrogen bonding sites and 
potentially an increased amount of nonspecific absorption.  
 
6.3.3 Degradation of Polymer Gels 
 
The degradation characteristics of the imprinted gels are particularly important if 
the polymers are to be used in therapeutic treatments.  The degradation of the 
network is a function of the crosslink density as well as the hydrolytic 
susceptibility of the polyester. Ultimately, it would be expected to have similar 
characteristics to the degradation of PLA and PGA.  
 
Several measures can be taken to design and tune the degradation rates. Highly 
crosslinked networks have slower degradation times than more loosely 
crosslinked polymers. Also, certain ester linkages are more hydrolytically 
susceptible than others, with the glycolidyl linkage being the most susceptible. 
Finally, the inclusion of PEG chains in the network will greatly affect its 
degradation rate. It has been shown that including PEG will reduce the amount of 
time it takes the network to degrade. This has been attributed to the fact that 
PEG is relatively hydrophilic and can solubilize larger molecular weight fragments 
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that would be soluble for a homopolymer such as PGA.  Also, PEG increases the 
accessibility of water to the polymer matrix which ensures bulk erosion [11-17]. 
 
The degradation profiles of the imprinted and non-imprinted control polymers, 
which were subjected to in vitro degradation, can be seen in Figure 6.7.  The 
total time taken for the gels to degrade into completely water soluble products at 
pH 7.4 and 37°C was 19 days. It should be noted, however, that the gels were 12 
mm circular disks with a thickness of 700 μm. It would, therefore, be assumed 
that if the same polymer formulation was used but was crushed into 
microparticles, the total degradation time would be much more rapid.  It is also 
interesting to notice that the addition of an imprinted template to the polymer 
formulation did not exert a significant effect on the degradation rate of the 
network.  The imprinted network had only a slightly more rapid initial rate which is 
possibly due to it being a more porous structure.  
 
The degradation products of the polymer were also analyzed by GPC. An 
example of a chromatograph can be seen in Figure 6.8.  The solution eluted over 
a period of 60 minutes. The elution peak at 41.6 minutes is the largest and the 
only peak that varies from the elution peaks of the blank solvent run and, 
therefore, corresponds to the polymer degradation products.  When compared to 
the standard PEO calibration curve, this yields a polymer molecular weight of 
986. It was not possible to calculate a PDI of the degradation products due to the 
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fact that that the polymer peaks are imbedded in the solvent peaks. The mw 
order of magnitude is, however, what one would expect if the polymer completely 
degraded because the original starting material was the nondegradable PEG 
1000.  
 
6.3.4 Analysis of Angiotensin II in Degradable Conditions 
 
The oligopeptide angiotensin II was tested for stability in various acidic conditions 
in order to determine whether or not acid byproducts from degradable polymers 
could be used as a therapeutic treatment for removing over-expressed peptides.   
 
The first goal of this work was to show proof of concept that the amino acid links 
of the peptide could be cleaved in acidic conditions. Therefore, the conditions 
were varied from extreme to more mild ones. The acids that the peptide was 
placed in included 70% lactic acid, 85% lactic acid, 6N HCl, 70% formic acid, 
70% THF and 70% glycolic acid. The temperature was also varied from 70°C to 
37°C. The higher temperature value was selected in order to provide an extreme 
environment for degradation by acting as a catalyst. The lower temperature was 
chosen to mimic physiological conditions. It was assumed that if there was no 
degradation of the peptide at 70°C after analyzing the solutions by mass 
spectrometry: the peptide would not degrade at 37°C. The time point of 24 hours 
was chosen as a representative time for a treatment such as this to be 
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considered viable. Ultimately, the only acidic environment capable of cleaving 
angiotensin II turned out to be one consisting of glycolic acid. At 70°C mass 
spectrometry showed complete destruction of the peptide with the original peak 
of 1046 no longer existing. At 37°C, mass spectrometry showed degradation 
peaks, but the 1046 peak still remained suggesting that some of the original 
peptide stayed intact. (Figure 6.9)  Overall, however, this shows that it is possible 
to degrade angiotensin II in a physiological environment with a 70% 
concentration of glycolic acid. 
 
Beyond showing that angiotensin II can be cleaved, these results are valuable 
because they give insight to important characteristics of the degradable network. 
They imply that the degradable crosslinker must contain glycolidyl moieties if it is 
to be used as a therapeutic treatment for removing excess angiotensin II. This is 
also promising because PGA degrades relatively faster that its hydrophobic 
poly(α-hydroxy-ester) cousin PLA, making it more suitable for rapid therapy. This 
is particularly desirable when trying to control over-expressed peptides that 
fluctuate on a daily basis as circadian and other period rhythms. 
 
6.4 Conclusions 
 
A poly(α−hyrdoxy ester) diacrylate crosslinker was successfully synthesized and 
incorporated into a network that is recognitive and selective for angiotensin II. 
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The FTIR analysis of the crosslinker showed that the correct structure was 
present but could not give a quantitative analysis of whether there were any 
impurities, such as nonacrylated chains, remaining. Although the synthesized 
crosslinker is similar is size, structure and function of the PEG 1000 DMA 
crosslinker that it is substituting for, there are some differences between the 
physical and recognitive abilities of the degradable and nondegradable networks. 
It is possible, however, that left over impurities from the synthesis lead to these 
differences. 
 
The degradable imprinted polymer is structurally sound and does show 
approximately a 28% selectivity of angiotensin II over another physiologically 
available peptide, ADH.  It also degrades at a relatively rapid rate due in part to 
the fact that it has glycolidyl ester linkages. This is significant because if the 
polymer is to be used as part of a treatment for removing over-expressed 
peptides, it has to be fast to recognize and quick to degrade. It is also the glycolic 
acid moieties that would be responsible for acting on or degrading the bound 
peptides. This is because it has been shown that glycolic acid has the ability to 
cleave angiotensin II and would render it inactive so as to prevent it from 
interacting with its receptors.  
 
Ultimately the results of this work are very promising because it is one of the first 
times molecularly imprinted systems have been shown to recognize a template 
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and degrade. By developing systems such as these, it is possible to broaden the 
scope of the molecular imprinting field, ultimately making it possible for imprinted 
systems to be successfully used in pharmaceutical treatments, drug delivery 
devices and tissue engineering constructs. 
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6.5  Figures 
 
 
 
 
 
Figure 6.1: Dual Bank Manifold 
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Figure 6.2: Reaction Scheme of Poly(α-hydroxy ester) diacrylate Synthesis 
and Degradation 
 
 
 
O ( C C
H
CH3 O
O)m (CH2 CH2 O)n ( C C O)m
O CH3
H
C CH CH2
O
C
O
CHCH2
O ( C C
H
CH3 O
O)m (CH2CH2 O)n ( C C O)m
O CH3
H
C
O
C
O
CHCH2
A
A
CH CH2
A
A
OH (CH2 CH2 O)n H OH C
CH3
COOH
H
( CH2 CH2)x
COOH
A A
Photopolymerization
Biodegradation
Stannous 
Octoate 200*
OH (CH2 CH2 O)n H
OH ( C C
H
CH3 O
O)m (CH2 CH2 O)n ( C C O)m
O CH3
H
H
CH
C
O
C
CH
O
CH3
CH3
O
O
Acryloyl Chloride 
Triethyl amine 
 
111
 
 
 
0
0.2
0.4
0.6
0.8
1
1.2
400140024003400
Wavenumber (cm-1)
 
 
Figure 6.3: FTIR Spectrogram 
FTIR spectrogram of α,ω-dihydroxy PEG 1000 precursor. The peak at 2880 cm-1 
is due to the C-H stretch, the peak at 1110 cm-1 is due to the ether stretch and 
the absorbance at 3510 cm-1 is due to the terminal hydroxyl group. 
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Figure 6.4: FTIR Spectrogram 
FTIR Spectrogram of pegylated poly(glycolic acid). The peak at 1756 cm-1 
shows the presence of an ester stretch due to glycolidyl moieties. 
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Figure 6.5: FTIR Spectrogram 
FTIR spectrogram of pegylated poly(glycolic acid) diacrylate. The low 
absorbance at 3510 cm-1 is due to acrylation of the free hydroxyl group. 
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Figure 6.6: Specific Recognition of Degradable Network  
Amount of peptide bound to polymer at a time point of 3hrs. n=3 * p=0.007, ** 
p=0.002 
 
 
 
 
 
 
0
10
20
30
40
50
60
70
Ang II SVA ADH
 imprinted polymers
nonimprinted polymers
%
 R
ec
og
ni
tio
n
*
**
 
115
-20
0
20
40
60
80
100
120
0 5 10 15 20
Time (days)
%
 D
eg
ra
da
tio
n
Imprinted Network
Nonimprinted Control
 
 
 
Figure 6.7: Percent Degradation over Time 
Degradation kinetics for the imprinted network and the nonimprinted controls. 
Degradation took place in PBS at a pH of 7.4 at 37°C. n=3. 
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Figure 6.8: GPC Chromatograph 
Elution peaks of degradation products. The large elution peak at 2496 sec 
corresponds to polymer peak. 
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Figure 6.9: ESI Mass Spectrograms  
ESI mass spectroscopy of pure angiotensin II (top) with 1046 peak and 
angiotensin II incubated in 70% glycolic acid for 24 hours (bottom). 
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7  INVESTIGATION OF CYTOCOMPATIBILITY OF CONFIGURATIONAL 
BIOMIMETIC IMPRINTED POLYMERS SELECTIVE FOR ANGIOTENSIN II 
 
 
7.1 Introduction 
 
 
When synthetic biomaterials are placed into a physiological environment, it is 
essential that they are not cytotoxic, or cause more damage than good. Testing 
this is particularly important for polymeric devices since the starting materials 
such as monomers, initiators and solvents are often toxic or not biocompatible 
themselves.  
 
Unreacted monomers and initiators are inherently toxic. However, in general 
terms when they become incorporated into a polymer network they are no longer 
dangerous. It must be noted though that during polymerization a 100% 
conversion is not achieved and unreacted monomers and initiator can become 
entrapped within the network. During use, these residues can migrate out and 
create cytotoxic effects. To minimize this, all biomaterials, including the polymer 
networks studied here, are washed twice a day for seven days. This has been 
shown to be a reasonable period to remove excess chemicals and unreacted 
monomers. [1] Also, since the polymerizations are free radical polymerizations, 
the start of each chain will incorporate the initiator into the polymer backbone 
also minimizing toxicity. In the present work, we performed a number of 
cytotoxicity and cellular studies using the newly developed, molecularly imprinted 
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hydrogels to investigate their biological behavior. Surprisingly enough, the 
literature on molecularly imprinted polymers does not typically include any 
biocompatibility studies.  
 
7.2 Materials and Methods 
 
7.2.1 Cell Culture 
 
Cytocompatibility experiments were performed using an NIH/3T3 murine 
fibroblast cell line (#CRL-1658; American Type Culture Collection (ATCC), 
Manassas, VA).  Cells were cultured in Dulbecco's modified Eagle's medium 
(DMEM) with 4 mM L-glutamine and which was adjusted to contain 1.5 g/L 
sodium bicarbonate and 4.5 g/L glucose (ATCC).  Media was also supplemented 
with 10% fetal calf serum (ATCC), 1% non-essential amino acids ((Mediatech) 
Herndon, VA), 100 U/ml penicillin and 100 μg/ml streptomycin (Mediatech).  The 
solution was then sterile filtered. 
 
Cells were cultured according to ATCC protocols under strictly aseptic 
conditions. The frozen culture vile was rapidly warmed to 37°C. The cells were 
then transferred to a centrifuge tube containing 9.0 milliliters of DMEM.  This 
mixture was spun at approximately 125 xg for 5 to 7 minutes.  After aspirating the 
media, the resulting cell pellet was resuspended with the complete growth 
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medium and dispensed into a 75 cm2 culture flask (T-75 flasks) (Corning, 
Corning, NY).   
 
Before the cell pellet was added, the culture flask charged with the appropriate 
amount of complete growth medium was placed in the incubator for at least 15 
minutes to establish the optimal pH range (7.0 – 7.6).  The culture was then 
incubated at 37°C in a 95% humidified environment and 5% CO2 atmosphere.  
During this time, the cell culture medium was changed approximately every two 
days. 
 
When the cells reached 70% confluency, which typically occurred between 3 and 
4 days after seeding, the cells were passaged. This was done by aspirating off 
the old medium. The flasks were then washed twice with 10 ml Dulbeccos 
Phophate Buffered Saline without CaCl2 and MgCl2 (DPBS, Sigma, St. Louis, 
MO) solution. The cells were then incubated with 5 ml of a 0.5% Trypsin/ 0.2% 
EDTA solution (Sigma) and incubated at 37°C for 5 minutes. Gentle agitation of 
the flasks caused the cells to detach at which time they could be counted and 
reseeded.  
 
Upon cell detachment, 8 ml of DMEM were added, and the cells were gently 
aspirated via pipetting to break up cell clumps and detach remaining cells.  A 
standard cell count was performed using a hemocytometer.   The suspension 
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was then centrifuged at 150xg for 5 min.  Upon completion, the remaining 
Trypsin/EDTA containing liquid was then aspirated off of the resulting cell pellet 
and replaced with fresh media to give a cell concentration of 3-5 X 103 cell/ cm2.  
Appropriate aliquots of the cell suspension were then added to new T-75 cm2 
culture flasks.  The culture flasks were incubated at 37°C under a 95% humidity 
and 5% CO2 atmosphere.   
 
7.2.2 Cytocompatibility Studies 
 
Cytotoxicity studies were conducted in 96 well plates (Corning) when cells 
reached ~90% confluency or above (3-4 days).  Cell studies were performed 
between passages 5-10.  Media was refreshed 12 hours before the experiment.  
At the start of the experiment, growth medium was removed from each well.  
 
CIBP and control microparticles were prepared as previously described. They 
were then added to wells at concentrations of 0.25 mg/mL, 0.5 mg/mL and 1.0 
mg/mL suspended in DMEM. The CIBP formulations that were used were 
pegylated poly(acrylamide-co-methacrylic acid) with a crosslinker percentage of 
40 mol% and a template to functional monomer ratio of 1:8. The formulation with 
the addition of the degradable crosslinker was also used.   Prior to addition of the 
polymer microparticles, the pH of each suspension was adjusted to 7.4 with 
NaOH.   Microparticles were then incubated with the cells for either 4 or 24 hours 
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at 37°C and 5% CO2.  The microparticle suspension was removed from each 
well, and the wells were rinsed three times with 200 µL Hanks Balanced Salt 
Solution (HBSS, Sigma) to remove microparticles and residual phenol red 
because this indicator is known to interfere with the absorbance readings of the 
assay.   
 
Cytotoxicity was measured using the CellTiter 96® AQueous One Solution Cell 
Proliferation Assay (Promega, Madison, WI).   This method is a cellular metabolic 
assay used to measure NADPH production to give an accurate count of viable 
cells [2].  This assay contains a tetrazolium compound, 3-(4,5-dimethylthiazol-2-
yl)-5-(3-carboxymethoxyphenyls)-2-(4-sulfophenyl)-2H-tetrazolium) (MTS), and 
an electron coupling reagent, phenazine ethosulfate (PES).  The MTS reagent is 
bioreduced by cells in culture to produce a colored formazan that is released into 
DMEM.  It is believed the mechanism of reduction is achieved by NADPH 
contained in dehydrogenase enzymes from metabolically active cells (Figure 
7.1).  The absorbance of the formazan can then be read via a plate reader and 
corresponded to the viable number of cells (Figure 7.2). 
 
A sample of 2 ml of assay reagent was suspended in 10 ml of HBSS.  Then, 120 
μL of the solution was added to each well and incubated with the cells for 1.5 
hours at 37°C and 5% CO2.  A UV/vis microplate reader (Bio-Tek Synergy HT, 
Winooski, VT) was then used to determine the absorbance in each well at 490 
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nm.  To determine cell viability, absorbance was compared to control wells that 
were not incubated with microparticles but only with HBSS and the CellTiter 96® 
reagent.  Background absorbance of control wells containing only cells and 
HBSS was subtracted from the results.  A 10% bleach solution was used as a 
negative control. 
 
7.3 Results and Discussion 
 
There was no significant decrease in cell viability when the various polymer 
formulations of the pegylated poly(acrylamide-co-methacrylic acid) network and 
its degradable counterpart were incubated with 3T3 fibroblasts. This was true for 
all concentrations of microparticles and at both time points of 4 h and 48 h. 
(Figure 7.3 and 7.4) Although there appeared to be some decrease in viability 
after 48 h, it was consistent with the control cells after normalization and was not 
considered to be a function of the polymer networks.   
 
These results were encouraging but anticipated because the components of the 
networks have been previously shown to be biocompatible. PEG is considered a 
highly biocompatible polymer, and PGA has been FDA approved based on its 
biocompatibility. [3] The results also correlate well to previous results in our 
laboratory using similar polymer components on a different cell line. Those 
results showed that grafting methacrylic acid to PEG at a 1:1 molar feed in 
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microparticle formulations did not have cytotoxic effects when placed in contact 
with Caco-2 cell lines. This was at concentrations of less than 10 mg/ml [4-7].  
 
These cytotoxicity results also suggest that potentially harmful network residues, 
such as any unreacted monomers and remaining photoinitiators in the polymer 
backbone, did not decrease cell viability. It can, therefore, be assumed that 
unreacted monomers have been adequately removed by washing steps. 
Photoinitiators, which have also been known to reduce cell viability, did not 
appear to have an effect either. Bryant et al. [8] and Williams et al. [9] concluded 
that the photoinitator Irgacure 184 often reduced cell viability in numerous 
different cell lines. However, these studies were conducted when the polymer 
was initiated and split into free radicals in the presence of cells.  In the 
recognitive networks, the polymer is initiated before it is placed into contact with 
cells, therefore preventing them from being exposed to harmful free radicals.  
 
7.4 Conclusions 
 
Ultimately, it is the goal of this work to be able to place molecularly imprinted 
polymers into physiological environments. It is, therefore, essential to ensure that 
the materials are biocompatible.  Although molecularly imprinted polymers have 
been well characterized and successfully used in many applications over the past 
several decades, there are no published results on their biocompatible nature. 
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These results are, therefore, some of the first of their kind to show that it is 
possible to create a recognitive network that does not exhibit any harmful 
biological side effects.  
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7.5 Figures 
 
 
 
 
 
Figure 7.1: Chemical Structures of MTS Tetrazolium and Formazan 
The CellTiter 96® AQueous One Solution Cell Proliferation Assay uses a MTS 
tetrazolium compound that is reduced to a colored formazan product by NADH or 
NADPH.  The colorimetric change is directly proportional to the number of viable 
cells in culture. Adapted from Promega [2] 
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Figure 7.2: Corresponding Increase in Absorbance as an Indicator of Cell 
Number. 
Figure reproduced from Promega [2]. 
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Figure 7.3:  Cytotoxicity of imprinted polymers to 3T3 fibroblasts after 4h 
Enzymatic activity of 3T3 cells after exposure to imprinted microparticles and 
10% bleach.  Results are expressed as the percentage of absorbance at 490 nm 
for a given microparticle concentration as compared to control wells containing 
only cells and HBSS.  Cell viability was maintained across all concentrations and 
formulations. n=3 
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Figure 7.4: Cytotoxicity of imprinted polymers to 3T3 fibroblasts after 48h. 
Enzymatic activity of 3T3 cells after exposure to increasing concentrations of 
imprinted microparticles and 10% bleach.  Results are expressed as the 
percentage of absorbance at 490 nm for a given microparticle concentration as 
compared to control wells containing only cells and HBSS.  Cell viability was 
maintained across all concentrations and formulations. n=3 
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8 CONCLUSIONS 
 
 
By investigating and understanding the molecular interactions of the human 
body, modern healthcare, which relies greatly upon diagnostic devices and drug 
delivery vehicles, can be greatly improved. In this field, there exists a great need 
for biocompatible materials which can be specifically tailored to interact with the 
shape and chemical properties of target molecules. To this end, the idea of 
molecular imprinting has emerged as a promising application in which synthetic 
materials are used in order to imitate the recognition capacity of natural systems 
towards specific ligands.  MIP polymers have shown a significant ability to be 
both selective and sensitive toward their target molecules.  The potential 
applications of MIP polymers are far reaching and extensive reviews have been 
published on their possible uses. This includes devices for affinity separations, 
antibody binding and enzyme mimetics, biomimetic sensors, clinical diagnostic 
devices and drug delivery vehicles [1-8]. 
 
Although imprinted polymers show great promise, the most successful MIP 
polymers have so far involved work containing smaller template molecules and 
ions. This is due primarily to the fact that large templates are less rigid. 
Ultimately, this can impair the formation of well-defined binding cavities during 
the imprinting process. Also, secondary and tertiary structures of large 
biomolecules are sometimes affected when exposed to the thermal or photo-
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induced treatment required during the synthesis process. Rebinding is also more 
challenging for large molecules due to the inherent diffusion limitations through 
the polymer networks [9-10]. In biological systems, imprinted systems face 
several unique challenges. This includes the challenge of the impairment of 
imprinting induced recognition and selectivity in aqueous media due to the 
competition in hydrogen bonding between the solvent and template [6]. Also, if 
the network is placed in a physiological environment, it is important to ensure that 
the network is biocompatible. Ideally, the system would also be able to degrade.  
 
Despite the challenges, the need exists to improve on currently available clinical 
diagnostic devices and DDS. The particular features of MIP polymers, which 
include their high affinity and selectivity compared to natural receptors, their 
unique stability that is superior to that of natural biomolecules, the simplicity of 
their preparation and the ease of adaptation to different practical applications, 
have made them the target of intense investigation [7]. 
 
This study shows one such investigation which was intended to present a 
possible solution to the many challenges posed by successfully imprinting larger 
biomolecules for physiological environments. An imprinted polymer which was 
able to recognize angiotensin II was effectively synthesized containing the 
functional monomers, methacrylic acid, acrylamide and PEG monomethacrylate. 
Various formulations and combinations of the monomers were studied in order to 
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determine which induced the best recognition of the peptide template. The 
synthesis process was carefully designed in order to create a successful 
recognition cavity. This included using DMSO as a solvent. Peptides and proteins 
maintain a similar hydrodynamic radius in DMSO as they do in water [11]. 
Therefore, the recognition cavities were able to maintain similar shape in an 
aqueous environment, minimizing negative effects during rebinding/recognition.  
Also, by including both acrylamide for hydrogen bonding and methacrylic acid for 
ionic bonding, these polymers were able to overcome the competition between 
the solvent and template and ultimately recognize the template molecule in an 
aqueous environment. The amount of crosslinking agent was also investigated in 
order to produce hydrogels that were able to maintain their physical integrity 
while at the same time allowing for sufficient diffusion of angiotensin II. The 
formulations were then tested in cytotoxic assays to determine their 
biocompatibility. In the end, the polymers, regardless of their specific formulation, 
did not exhibit any cytotoxic effects, indicating their biocompatible nature. 
 
These materials were also studied via several characterization techniques to 
better understand their properties.  SEM was used to study the porosity and 
microscopic features of the MIPs.  The SEM images showed that the presence of 
the template protein had an effect on the polymerization, forming a more porous 
and structured polymer as compared to the controls.  FTIR was used to confirm 
the presence of each of the monomers in the copolymer formulations as well as 
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to demonstrate the fact that the MIPs and control polymers are chemically 
identical.  DSC was used to determine the glass transition temperatures of the 
crosslinked hydrogels and, from such information, the effective molecular weight 
between crosslinks.  These values were compared to the theoretical molecular 
weight between crosslinks to ensure the validity of the observed Tg values.   
 
This study was also the first of its kind to investigate the effects of adding a 
degradable crosslinker to the imprinted material. A poly(α−hyrdoxy ester) 
diacrylate crosslinker was successfully synthesized and incorporated into a 
network which remained recognitive and selective for angiotensin II. This 
degradable formulation was also found to be biocompatible in nature.  
 
In the end, this study showed the successful creation of a biocompatible and 
biodegradable MIP polymer for a larger peptide.  Key steps taken in the design 
and synthesis of the imprinted network allowed for binding in aqueous 
environments. Since angiotensin II is a model peptide and contains many 
attributes found in other peptides, these techniques can be readily expanded to 
additional peptides and/or proteins. By developing systems such as these, it is 
possible to broaden the scope of the molecular imprinting field, ultimately making 
it possible for imprinted systems to be successfully used in pharmaceutical 
treatments, drug delivery devices and tissue engineering constructs. 
 
 
139
8.1 References Cited 
 
1. Wulff, G., Molecular imprinting in crosslinked materials with the aid of 
molecular templates—a way towards artificial antibodies. Angew. Chem. Int. Ed. 
Engl., 1995, 34: 1812-1832 
 
2. Shea, K. J., Molecular imprinting of synthetic network polymers: the de 
novo synthesis of macromolecular binding and catalytic sites. Trends Polym. Sci, 
1994, 2: 166-173 
 
3. Mosbach, K., Ramstroem O., The emerging technique of molecular 
imprinting and its future impact on biotechnology. Bio/Technology, 1996, 14:163-
170 
 
4. Steinke, J., Sherrington, D.C., Dunkin, I.R., Imprinting of synthetic 
polymers using molecular templates. Adv. Polym. Sci., 1995, 123: 81-125 
 
5. Allender, C.J., Richardson, C., Woodhouse, B., Heard, C.M., Brain, K.R., 
Pharmaceutical applications for molecularly imprinted polymers.  Int. J. Pharm. 
2000, 195: 39-43 
 
6.  Silvestri, D., Barbani, N., Cristallini, C., Guisti, P., Ciardelli, G., Molecularly 
imprinted membranes for an improved recognition of biomolecules in aqueous 
medium. J. Membr. Sci. 2006, 282: 284-295 
 
7.  Piletsky, S.A., Turner, N.W., Laitenberger, P., Molecularly imprinted 
polymers in clinical diagnostics – Future potential and existing problems. Med. 
Engr. Phys. 2006, 28: 971-977 
 
 
140
8. Byrne ME, Park K, Peppas, NA. Molecular imprinting within hydrogels. 
Adv Drug Deliv Rev, 2002; 54:149-61 
 
9. Wolman, F.J., Smolko, E.F., Cascone, O., Grasselli, M., Peptide imprinted 
polymer synthesized by radiation-induced graft polymerization. J. React. Funct. 
Polym. 2006, 66:1199-1205 
 
10. Mahony, J.O., Nolan, K., Smyth, M.R., Mizaikoff, B., Molecularly imprinted 
polymers-potential and challenges in analytical chemistry. Anal. Chim. Acta, 
2005, 534: 31-39 
 
11. Spizzirri, U.G.; Peppas, N. A.; Structural Analysis and Diffusional Behavior 
of Molecularly Imprinted Polymer Networks for Cholesterol Recognition, Chem. 
Mater., 2005; 17: 6719-6727  
 
 
 
 
 
 
 
 
 
 
 
141
 
 BIBLIOGRAPHY 
 
 
Allcock, H.R.; Lampe, F.W.; Mark, J.E.; Contemporary Polymer Chemistry Third 
Edn, Pearson Education Inc., Upper Saddle River, New Jersey, 2003 
 
Allender, C.J., Richardson, C., Woodhouse, B., Heard, C.M., Brain, K.R., 
Pharmaceutical applications for molecularly imprinted polymers.  Int. J. Pharm. 
2000, 195: 39-43 
 
Alvarez-Lorenzo, C. H., H.; Gomez-Amoza, J.L.; Martinez-Pacheco, R.; Souto, 
C.; Concheiro, A., Soft Contact Lenses Capable of Sustained Delivery of Timolol. 
J. Pharm. Sci. 2002, 91; 2182-2192 
Alvarez-Lorenzo, C.; Guney, O.; Oya, T.; Sakai, Y.; Kobayashi, M.; Enoki, T.; 
Takeoka, Y.; Ishibashi, T.; Kuroda, K.; Tanaka, K.; Wang, G. Q.; Grosberg, A. Y.; 
Masamune, S.; Tanaka, T., Polymer Gels That Memorize Elements of Molecular 
Conformation. Macromolecules 2000, 33, 8693-8697. 
 
Alvarez-Lorenzo, C.; Guney, O.; Oya, T.; Sakai, Y.; Kobayashi, M.; Enoki, T.; 
Takeoka, Y.; Ishibashi, T.; Kuroda, K.; Tanaka, K.; Wang, G. Q.; Grosberg, A. Y.; 
Masamune, S.; Tanaka, T., Reversible Adsorption of Calcium Ions by Imprinted 
Temperature Sensitive Gels. J. Chem. Phys. 2001, 114, 2812-2816. 
 
Alvarez-Lorenzo, C.; Hiratani, H.; Tanaka, K.; Stancil, K.; Grosberg, A.; Tanaka, 
T., Simultaneous Multiple-Point Adsorption of Aluminum Ions and Charged 
 
142
Molecules a Polyampholyte Thermosensitive Gel: Controlling Frustrations in a 
Heteropolymer Gel. Langmuir 2001, 17: 3616-3622 
Alvarez-Lorenzo, C.; Concheiro, A., Molecularly Imprinted Polymers for Drug 
Delivery. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2004, 804: 231-245 
Am Ende MT., Peppas NA., FTIR spectroscopic investigation and modeling of 
solute/polymer interactions in the hydrated state. J Biomater Sci Polym Ed, 1999; 
10: 1289-1302 
 
Ball, P. Designing the Molecular Word: Chemistry at the Frontier. Princeton 
University Press, 1994, 145-185 
 
Bargiello, T.A., F.R. Jackson, M.W. Young, Restoration of circadian behavioral 
rhythms by gene transfer in drosophila, Nature, 1984; 312: 752-754 
 
Barnes, J.P., Circadian variation in airway function, Am. J. Med.,1985; 79: 5-9 
 
Barnes, J.P., Autonomic control of the airways and nocturnal asthma as a absis 
for drug treatment, in B. Lemmer eds., Chronopharmacology – Cellular and 
Biochemical Interactions, pp. 53-63, New York, Basel, Marcel Dekker, 1989 
 
Bell, C.L., Peppas, N.A., Water, solute and protein diffusion in physiologically 
responsive hydrogels of poly(methacrylic acid-g-ethylene glycol), Biomaterials, 
1996; 17:1203-1218 
 
Bergmann N., Lauten EH., Peppas NA. Intelligent Biomaterials for Drug Delivery: 
Combining Molecular Recognition with Drug Delivery. Drug Deliv Sys Sci, 2005; 
4: 35-40. 
 
143
 
Blanchette, J. and Peppas, N.A., Oral chemotherapeutic delivery: design and 
cellular response. Ann Biomed Eng, 2005; 33: 142-149 
 
Brannon-Peppas L, Vert M. Polylactic and Polyglycolic Acids as Drug Delivery 
Carriers. In: Handbook of Pharmaceutical Controlled Release Technology 2000; 
p. 99-130  
 
Brannon-Peppas L. Recent advances on the use of biodegradable microparticles 
and nanoparticles in controlled drug delivery. Int Journal Pharm 1995; 116: 1-9 
 
Bryant, S. J.; Nuttelman, C. R.; Anseth, K. S.; Cytocompatability of UV and 
visible light photoinitiating systems on cultured NIH/3T3 fibroblasts in vitro. J. 
Biomater Sci Polym Ed,  2000; 11: 439-457 
 
 
Bures P, Huang Y, Oral E, Peppas NA. Surface modifications and molecular 
imprinting of polymers in medical and pharmaceutical applications. J Controlled 
Release 2001; 72:25-33 
 
Byrne, M.E.; Park K.; Peppas, N.A.; Non-Covalent Molecular Imprinting of 
Glucose: Recognition in Aqueous Media in Molecularly Imprinted Polymer 
Science and Technology, K.R. Brain and C.J. Alexander, eds., 111, STS 
Publishing, Cardiff, 2000 
 
Byrne ME, Park K, Peppas, NA. Molecular imprinting within hydrogels. Adv Drug 
Deliv Rev, 2002; 54:149-61. 
 
 
144
Cohen, Y.; Victor, G., On the origin of inhomogeneities in acrylamide hydrogels. 
Networks and Free Volume, 2006 
 
Dilaveris P., Giannopoulos G., Synetos A., Stefanadis C.,  The role of rennin 
angiotensin system blockade in the treatment of atrial fibrillation. Curr Drug 
Targets Cardiovasc Haematol Disord 2005, 5,387-403 
 
Deng, X. M.; Xiong, C. D.; Cheng, L. M.; Xu, R. P., Synthesis and 
Characterization of block copolymers from D, L-lactide and Poly(ethylene-glycol) 
with Stannous Chloride, J Polym Sci, Polym Let. Ed 1990; 28:  411-16 
 
Enoki, T.; Tanaka, K.; Watanabe, T.; Oya, T.; Sakiyama, T.; Takeoka, Y.; Ito, K.; 
Wang, G. Q.; Annaka, M.; Hara, K.; Du, R.; Chuang, J.; Wasserman, K.; 
Grosberg, A. Y.; Masamune, S.; Tanaka, T., Frustrations in Polymer 
Conformation in Gels and Their Minimization through Molecular Imprinting. Phys. 
Rev. Lett. 2000, 85: 5000-5003 
Foss, A.C. and Peppas, N.A., Investigation of the cytotoxicity and insulin 
transport of acrylic-based copolymer protein delivery systems in contact with 
caco-2 cultures. Eur J Pharm Biopharm, 2004; 57: 447-455 
 
Gekakis, N., L. Saez, A. Delahaye-Brown, M.P. Myers, A. Seghal, M.W. Young, 
C.J. Weitz, Isolation of timeless by PER protein interaction: defective interaction 
between timeless protein and long-period mutant PER, Science,1995; 270: 811-
815 
 
Gelato, M.C., R.S. Rittmaster, O.H. Pescovitz, M.C. Nicoletti, W.E. Nixon, R. 
D'Agata, D.L. Loriaux, G.R. Merriam, Growth hormone responses to continuous 
 
145
infusions of growth hormone releasing hormone, J Clin Endocrinol  Metab,1985; 
61: 223-228 
 
Glick BR and Pasternak JJ. in Molecular biotechnology: Principles and 
applications of recombinant DNA. Washington D.C., ASM Press, 1998; 235-237 
 
Goldbart, R.; Kost, J., Calcium Responsive Bioerodible Drug Delivery System. 
Pharm. Res. 1999, 16: 1483-1486 
Grayson AC, Cima MJ., Langer R. Size and temperature effects on poly(lactic-
co-glycolic acid) degradation and microreservoir device performance. 
Biomaterials, 2005; 26: 2137-2145 
 
Greiner, J.W., F. Guadagni, P. Noguchi, S. Pestka, D. Colcher, P.B. Fisher, J. 
Schlom, Recombinant interferon enhances monoclonal-antibody targeting of 
carcinoma lessions in vivo, Science, 1987; 235: 895-898 
 
Grulke, E. A. Polymer Process Engineering; TPS Publishing: Lexington, KY, 
1994; p 239. 
 
Haupt K and Mosbach K. Plastic antibodies: Developments and applications. 
Trends in Biotechnol 1998; 16: 468-475 
 
Helle, F.; Vagnes, O.B.; Iversen, B.M.; Angiotensin II-induced calcium signaling 
in the afferent arteriole from rats with two-kidney, one-clip hypertension, Am J 
Physiol Renal Physiol, 2006; 291: F140-F147  
 
 
146
Heller, J.Y.; Maa, F.; Wuthrich, S. Y.; Ng, J.; Duncan, R.; Recent Developments 
in the Synthesis and Utilization of Poly(ortho Esters). J. Controlled Release, 
1991; 16: 3-13 
 
Hiratani, H.; Alvarez-Lorenzo, C.; Chuang, J.; Guney, O.; Grosberg, A.; Tanaka, 
T., Effect of Reversible Cross-Linker, N,N '-Bis(Acryloyl)Cystamine, on Calcium 
Ion Adsorption by Imprinted Gels. Langmuir 2001, 17: 4431-4436 
 
Ho, S. M.; Young, A. M.; Synthesis, Polymerization and Degradation of 
Poly(lactide-co-propylene glycol) dimethacrylate adhesives, Eur. Polymer J., 
2006; 42: 1775-1785 
 
Ichikawa, H. and Peppas, N.A., Novel complexation hydrogels for oral peptide 
delivery: in vitro evaluation of their cytocompatibility and insulin-transport 
enhancing effects using Caco-2 cell monolayers. J Biomed Mater Res A, 2003, 
67: 609-617 
 
Kataoka, K.; Miyazaki, H.; Bunya, M.; Okano, T.; Sakurai, Y., On-Off Regulation 
of Insulin-Release by Totally Synthetic Polymer Gels Responding to External 
Glucose Concentration. Abstr. Pap. Am. Chem. Soc. 1999, 217: U564-U564 
Kim B., Peppas NA., Analysis of molecular interactions in poly(methacrylic acid-
g-ethylene glycol) hydrogels. Polymer 2003; 44: 3701-3707 
 
Konopka R.J., S. Benzer, Clock mutants of Drosophila melanogaster, Proc. Natl. 
Acad. Sci. USA, 1971; 68: 2112-2114 
 
Langer, R.; New Methods of Drug Delivery. Science, 1990; 249: 1527-1533 
 
147
 
Lemmer, B., The clinical relevance of chronopharmacology in therapeutics, 
Pharm. Res.,1996; 33: 107-115 
 
Lemmer B., The importance of circadian rhythms on drug response in 
hypertension and coronary heart disease – from mice and man.  Pharmacol Ther 
2006, 111, 629 - 651 
 
Li S. Hydrolytic degradation characteristics of aliphatic polyesters derived from 
lactic and glycolic acids. J Biomed Mater  Res, 1999; 48:342-353  
 
Li, W. J.; Cooper, J. A.; Mauck, R. L.; Taun, R. S.; Fabrication and 
Characterization of Six Electrospun Poly(α−hydroxy ester)-based Fibrous 
Scaffolds for Tissue Engineering Applications, Act. Biomat., 2006; 2: 377-385 
 
Li, Q.; Wang, J.; Shahani, S.; Sun, D. D. N.; Sharma, B.; Elisseeff, J. H.; Leong, 
K. W.; Biodegradable and photocrosslinkable polyphosphoester hydrogel. 
Biomaterials,  2006; 27: 1027-1034 
 
Lu, Y.; Li, C.; Wang, X.; Sun, P.; Xing, X., Influence of Polymerization 
Temperature on the Molecular Recognition of Imprinted Polymers. J. 
Chromatrogr. B 2004; 804, 1: 53-59. 
Mahony JO., Nolan K., Smyth MR., Mizaikoff B. Molecularly imprinted polymers-
potential and challenges in analytical chemistry. Anal Chim Acta, 2005; 534: 31-
39. 
 
Meislin, R. J.; Wiseman, D. M.; Alexander, H.; Cunningham, T.; Linksky, C.; 
Carlstedt, C.; Pitman, M.;  Casar, R.; A Biochemical Study of Tendon Adhesion 
 
148
Reduction Using a Biodegradable Barrier in a Rabbit Model. J. Appl. Biomat., 
1990; 1: 13-19 
 
Miller, R. A.; Brady, J. M.; Cutright, D. E., Degradation rates of oral resorbable 
implants (polylactates and polyglycolates): Rate modification with changes in 
PLA/PGA copolymer ratios J. Biomed. Mater. Res. 1977; 11: 711-719 
 
Miyata, T.; Asami, N.; Uragami, T., A Reversibly Antigen-Responsive Hydrogel. 
Nature 1999, 399: 766-769 
Mosbach K.; Molecular imprinting. Trends Biochem Sci, 1994; 19: 9-14. 
 
Mosbach, K., Ramstroem O., The emerging technique of molecular imprinting 
and its future impact on biotechnology. Bio/Technology, 1996, 14:163-170 
 
Mosbach K. Toward the next generation of molecular imprinting with emphasis 
on the formation, by direct molding, of compounds with biological activity 
(biomimetics). Anal Chim Acta 2001; 435: 3-8  
 
Motherwell WB, Bingham MJ and Six Y. Recent progress in the design and 
synthesis of artificial enzymes. Tetrahedron 2001; 57: 4663-4686 
 
Myers, M.P., K. Wager-Smith, C.S. Wesley M.W. Young, A. Seghal, Positional 
cloning and sequences analysis of the Drosophila clock gene, timeless, Science, 
1995; 270: 805-808 
 
Nicholls, I.A., Towards the rational design of molecularly imprinted polymers, J. 
Mol. Recognit. 1998, 11: 79-82 
 
 
149
Oral E and Peppas N. Molecular imprinting in biological systems. STP Pharma 
Sciences 2000; 10: 261-267  
 
Oral E and Peppas N. Responsive and recognitive hydrogels using star 
polymers. J Biomed Mater  Res,  2004; 68A: 439-447 
 
Pariente JL., Kim BS., Atala A. In vitro biocompatibility evaluation of naturally 
derived and synthetic biomaterials using normal human bladder smooth muscle 
cells.  Journal of Urology 2002; 167: 1867-1871. 
 
Park, K.; Shalaby, W. S. W.; Park, H.; Biodegradation in Biodegradable 
Hydrogels for Drug Delivery, Technomic Publishing AG: Basel, Switzerland, 
1993, 13-34 
 
Peppas, N.A., Hydrogels in Medicine, CRS Press, Boca Raton, FL, 1986 
 
Peppas, N.A., Physiological responsive gels, J. Bioact. Compat. Polym., 1991;  
6:  241-246 
 
Peppas, N. A.; Khare, A. R., Preparation, Structure and Diffusional Behavior of 
Hydrogels in Controlled-Release. Adv. Drug Deliv. Rev. 1993, 11: 1-35 
Peppas, N.A., P. Colombo, Analysis of drug release behavior from swellable 
polymer carriers using the dimensionality index, J. Controlled Release, 1997; 45: 
35-40 
 
Peppas, N. A.; Bures, P.; Leobandung, W.; Ichikawa, H., Hydrogels in 
Pharmaceutical Formulations. Eur. J. Pharm. Biopharm. 2000, 50: 27-46 
 
150
Peppas N and Huang Y. Polymers and gels as molecular recognition agents. 
Pharm Res 2002; 19: 578-587  
 
Piletsky, S.A., Turner, N.W., Laitenberger, P., Molecularly imprinted polymers in 
clinical diagnostics – Future potential and existing problems. Med. Engr. Phys. 
2006, 28: 971-977 
 
Pitt, C. G.; Gratzel, M. M.; Kimmel, G. L.; Surles, J.; Schindler, A., Aliphatic 
polyesters II. The degradation of poly (DL-lactide), poly ( -caprolactone), and 
their copolymers in vivo, Biomaterials 1981; 2: 215-220 
 
Pitt, C. G.; Schindler, A.; Chapter 3 in Controlled Drug Delivery, Vol. 1 Basic 
Concepts, CRC Press: S.D. Bruck, ed., Boca Raton, FL 1983 
 
Promega, Celltiter 96® AQueous One Solution Cell Proliferation Assay, 
Technical Bulletin. 2005 
 
Rachkov A and Minoura N. Towards molecularly imprinted polymers selective to 
peptides and proteins. The epitope approach. Biochimica et Biophysica Acta 
(BBA) - Protein Structure and Molecular Enzymology 2001; 1544: 255-266 
 
Rexzwan, K; Chen, Q. Z.; Blaker, J. J., Boccaccini, A. R., Biodegradable and 
Bioactive Porous Polymer/inorganic Composite Scaffolds for Bone Tissue 
Engineering, J. Biomat.,  2006; 27: 3413-3431 
 
Salins, L. L. E.; Deo, S. K.; Daunert, S., Phosphate Binding Protein as the 
Biorecognition Element in a Biosensor for Phosphate. Sens. Actuators, B 2004, 
97: 81-89 
 
151
Sanders, S.W., A.L Bishop, J.G. Moore, Intragastric pH and pharmacokinetics of 
intravenous ranitidine during sinusoidal and constant rate infusions, Chronobiol 
Int.,1991;  8: 267-273 
 
Sawhney A.S.; Pathak C.P; Hubbell J.A.; Bioerodible hydrogels based on 
photopolymerized  poly(ethylene glycol)-co-poly(a-hydroxy acid) diacrylate 
macromers.  Macromolecules, 1993; 26: 581-587 
 
Seghal, A., A. Rothenfluh-Hilfiker, M. Hunter-Ensor, Y. Chen, M.P. Myers, M.W. 
Young, Rhythmic expression of timeless: a basis for promoting circadian cycles 
in period gene autoregulation, Science, 1995; 270: 808-810  
 
Sellergren B., Noncovalent molecular imprinting: Antibody-like molecular 
recognition in polymeric network materials. Trends Anal Chem 1997; 16: 310-
320. 
 
Schoen, F. J.; Mitchell, R. N., Tissues, the Extracellular Matrix, and Cell-
Biomaterial Interactions. In Biomaterials Science: An Introduciton to Materials in 
Medicine, 2 ed.; Ratner, B. D.; Hoffmann, A. S.; Schoen, F. J.; Lemons, J. E., 
Eds. Elsevier, Inc.: San Diego, 2004; pp 260-281 
 
Scott, R.A.; Peppas, N.A.; Compositional Effects on Network Structure of Highly 
Crosslinked Copolymers of PEG-Containing Multiacrylates with Acrylic Acid, 
Macromolecules, 1999; 32: 6139-6148  
 
Shea, K. J., Molecular imprinting of synthetic network polymers: the de novo 
synthesis of macromolecular binding and catalytic sites. Trends Polym. Sci, 
1994, 2: 166-173 
 
 
152
Sheih, S.J.; Zimmerman, M.C.; Parsons, J.R.; Preliminary Characterization of 
Bioresorable and Nonresorbable Synthetic Fibers for the Repair of Soft Tissue 
Injuries. J. Biomed. Mater. Res.,1990; 24:789-808. 
 
Sherwood L., Human Physiology From Cells to Systems. Pacific Grove, CA: 
Brooks/Cole, 2001 
 
Silvestri, D., Barbani, N., Cristallini, C., Guisti, P., Ciardelli, G., Molecularly 
imprinted membranes for an improved recognition of biomolecules in aqueous 
medium. J. Membr. Sci. 2006, 282: 284-295 
 
Slade CJ. Molecular (or bio-) imprinting of bovine serum albumin. J Mol Catal B: 
Enzymatic 2000; 9: 97-105  
 
Smolensky, M.H, Chronopharmacology of theophylline and beta-
sympathomimethics, in B. Lemmer eds., Chronopharmacology – Cellular and 
Biochemical Interactions, pp. 65-113, New York, Basel, Marcel Dekker, 1989 
 
Smolensky M.H., Haus E. Circadian rhythms in clinical medicine with applications 
to hypertension. American Journal of Hypertension 2001; 14: 280S-290S 
 
Spizzirri, U.G.; Peppas, N. A.; Structural Analysis and Diffusional Behavior of 
Molecularly Imprinted Polymer Networks for Cholesterol Recognition, Chem. 
Mater., 2005; 17: 6719-6727  
 
Steinke, J., Sherrington, D.C., Dunkin, I.R., Imprinting of synthetic polymers 
using molecular templates. Adv. Polym. Sci., 1995, 123: 81-125 
 
 
153
St. Pierre, T.; Chiellini, E.; Biodegradability of Synthetic Polymers Used for 
Medical and Pharmaceutical Applications: Part 1-Principles of Hydrolysis 
Mechanisms. J. Bioact. Compat. Polymers, 1986; 1: 467-497 
 
Thomas, A. A.; Kim, I.T.; Kiser, P. F.; Symmetrical Biodegradable Crosslinkers 
for use in Polymeric Devices, Tetra. Letters, 2005; 46: 8921-8925 
 
Torres-Lugo, M., Garcia, M., Record, R., and Peppas, N.A., Physicochemical 
behavior and cytotoxic effects of p(methacrylic acid-g-ethylene glycol) 
nanospheres for oral delivery of proteins. J Controlled Release, 2002; 80: 197-
205 
 
Uchimura, E.; Otsuka, H.; Okano, T.; Sakurai, Y.; Kataoka, K., Totally Synthetic 
Polymer with Lectin-Like Function: Induction of Killer Cells by the Copolymer of 
3-Acrylamidophenylboronic Acid with N,N-Dimethylacrylamide. Biotechnol. 
Bioeng. 2001, 72: 307-314 
Unger T., Schoelkens BA. Angiotensin Volume 1. Berlin: Springer, 2004 
 
Uphill, P. F. and Christopher, D. H. Developing a positive control for cytotoxicity 
testing of medical device materials. Medical Device Technology 1990; 24 
 
Vlatakis G, Andersson LI, Muller R and Mosbach K. Drug assay using antibody 
mimics made by molecular imprinting. Nature 1993; 361: 645-646 
 
Ward, J. H.; Peppas, N.A.; Preparation of Controlled Release Systems by Free-
radical UV Polymerizations in the Presence of a Drug,  J. Controlled Release, 
2001; 71: 183-192 
 
 
154
Ward, J.H.; Furman, K.; Peppas, N. A.; Effect of Monomer Type and Dangling 
End Size on Polymer Network Synthesis, J. Appl Polym Sci, 2003; 89: 3506-
3519  
 
Wang, H.Y., Kobayashi, T., Fuji, N., Surface molecular imprinting on 
photosensitive dithiocarbamoyl polyacetonitrile membranes using photograph 
polymerization. J. Chem. Technol. Biotechnol. 1997; 70: 355-362 
 
Wang, H. Y.; Xia, S. L.; Sun, H.; Liu, Y. K.; Cao, S. K.; Kobayashi, T., Molecularly 
Imprinted Copolymer Membranes Functionalized by Phase Inversion Imprinting 
for Uracil Recognition and Permselective Binding. J. Chromatogr. B Analyt. 
Technol. Biomed. Life Sci. 2004; 804, 1, 127-134. 
 
Westh, P. Thermal Expansivity, Molar Volume, and Heat Capacity of Liquid 
Dimethyl Sulfoxide-Water Mixtures at Subzero Temperatures, J. Phys Chem., 
1994; 98: 3222-3225 
 
Whitcombe M and Rodriguez M, Villar P, Vulfson EN. A new method for the 
introduction of recognition site functionality into polymers prepared by molecular 
imprinting: Synthesis and characterization of polymeric receptors for cholesterol. 
J Am Cheml Soc, 1995; 117: 7105-7111. 
  
Williams, C.G., Malik, A.N., Kim, T.K., Manson, P.N., and Elisseeff, J.H., Variable 
cytocompatibility of six cell lines with photoinitiators used for polymerizing 
hydrogels and cell encapsulation. Biomaterials, 2005; 26: 1211-1218 
 
Wolman, F.J., Smolko, E.F., Cascone, O., Grasselli, M., Peptide imprinted 
polymer synthesized by radiation-induced graft polymerization. J. React. Funct. 
Polym. 2006, 66:1199-1205 
 
155
 
Wulff, G., Molecular imprinting in crosslinked materials with the aid of molecular 
templates—a way towards artificial antibodies. Angew. Chem. Int. Ed. Engl., 
1995, 34: 1812-1832 
 
Wulff G. and Knorr K. Stoichiometric noncovalent interaction in molecular 
imprinting.  Bioseparation 2000; 10: 257-276 
 
Yoshikawa, M.; Shiota, A.; Sanui, K.; Ogata, N., Preparation of polyoxyethylene 
hydrogel membranes and their ultrafiltration performance, New Polym. Mater. 
1989; 1: 223-234 
 
Yoshikawa, M., Izumi, J., Kitao, T. Enantioselective electrodialysis of N-
alphaacetyltryptophans through molecularly imprinted polymeric membranes. 
Chem. Lett. 1996; 8: 611-612 
 
Yu, S.; Chow, G. M., Carboxyl Group (-CO2H) Functionalized Ferrimagnetic Iron 
Oxide Nanoparticles for Potential Bio-Applications. J. Mater. Chem. 2004; 18: 
2781-2786 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
156
 
VITA 
 
Elizabeth Hunter Lauten was born in Greenville, South Carolina on June 
27, 1979. After completing work at Phillips Andover Academy in 1997, she 
enrolled at Vanderbilt University. She received her Bachelor of Engineering 
degree in Biomedical Engineering from Vanderbilt University in 2001. Following 
graduation, she spent one year on a National Science Foundation fellowship 
interning at Solvay Pharmaceuticals in Hanover Germany. She started work 
towards her doctorate in Biomedical Engineering with Professor Nicholas A. 
Peppas at The University of Texas at Austin in the fall of 2002. She subsequently 
received a NSF/IGERT Graduate Fellowship. She expects to complete her 
doctoral degree in December 2006. 
 
 
Permanent Address: 3111 Parker Ln, Austin, TX 78741 
 
This dissertation was typed by the author. 
 
 
 
